<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Recent advances in the accessibility, synthetic utility, and biological applications of aziridines  - Organic &amp; Biomolecular Chemistry (RSC Publishing) DOI:10.1039/D3OB00424D</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2023/ob/d3ob00424d"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":31,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Christian Dank"/><meta name="DC.Creator" content="Laura Ielo"/><meta name="DC.title" content="Recent advances in the accessibility, synthetic utility, and biological applications of aziridines "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2023/06/07"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D3OB00424D"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Recent advances in the accessibility, synthetic utility, and biological applications of aziridines "/><meta name="citation_author" content="Christian Dank"/><meta name="citation_author" content="Laura Ielo"/><meta name="citation_online_date" content="2023/05/15"/><meta name="citation_date" content="2023"/><meta name="citation_journal_title" content="Organic &amp; Biomolecular Chemistry"/><meta name="citation_volume" content="21"/><meta name="citation_issue" content="22"/><meta name="citation_firstpage" content="4553"/><meta name="citation_lastpage" content="4573"/><meta name="citation_doi" content="10.1039/D3OB00424D"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2023/ob/d3ob00424d"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2023/ob/d3ob00424d"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2023/ob/d3ob00424d"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2023/ob/d3ob00424d">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d3ob00509g)" href="/en/content/articlehtml/2023/ob/d3ob00509g" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d3ob00650f)" href="/en/content/articlehtml/2023/ob/d3ob00650f" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D3OB00424D">10.1039/D3OB00424D</a>
(Review Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/1477-0539/2003">Org. Biomol. Chem.</a></span>, 2023, <strong>21</strong>, 4553-4573</div><h1 id="sect259"><span class="title_heading">Recent advances in the accessibility, synthetic utility, and biological applications of aziridines</span></h1><p class="header_text">
      <span class="bold">
        
          
            Christian 
            Dank
          
          
        
      </span><sup><span class="sup_ref italic">a</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Laura 
            Ielo
          
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Laura Ielo (orcid.org/0000-0001-9976-0170) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-9976-0170"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">b</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Institute of Organic Chemistry, University of Vienna, Währinger Strasse 38, 1090 Vienna, Austria</span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Department of Chemistry, University of Turin, Via P. Giuria 7, 10125 Torino, Italy. E-mail: <a href="mailto:laura.ielo@unito.it">laura.ielo@unito.it</a></span>
    </p><div id="art-admin"><span class="italic bold">Received 
      18th March 2023
    </span><span class="bold italic">, Accepted 12th May 2023</span></div><p class="bold italic">First published on 15th May 2023</p><hr/><div class="abstract"><h2>Abstract</h2><p>Compounds featuring aziridine moieties are widely known and extensively reported in the literature. Due to their great potential from both synthetic and pharmacological points of view, many researchers have focused their efforts on the development of new methodologies for the preparation and transformation of these interesting compounds. Over the years, more and more ways to obtain molecules bearing these three-membered functional groups, which are challenging due to their inherent reactivity, have been described. Among them, several are more sustainable. In this review, we report the recent advances in the biological and chemical evolution of aziridine derivatives, in particular, the variety of methodologies described for the synthesis of aziridines and their chemical transformations leading to the formation of interesting derivatives, such as 4–7 membered heterocycles of pharmaceutical interest due to their promising biological activities.</p></div><hr/><table><tr><td class="biogPlate"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-p1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-p1.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-p1.gif"/></a><p><span class="graphic_title">Christian Dank</span></p></td><td><i><p>Christian Dank pursued studies in chemistry at the University of Vienna, Austria. After obtaining the Master of Science (M.Sc.) degree in the group of Prof. Johann Mulzer in the field of total synthesis, during his Ph.D., he worked on the syntheses of novel antimalarials, supervised by Dr Hubert Gstach and Prof. Walther Schmid. After his Ph.D., he joined the medicinal chemistry department of Boehringer Ingelheim in Vienna, working on oncology projects for two and a half years. During his postdoctoral fellowship in the Lautens group in Toronto, Ontario, Canada, he contributed to his fields of expertise, total synthesis and medicinal chemistry, and explored the field of metal catalysis. Currently, he is teaching at his alma mater, the University of Vienna, as a senior lecturer. His current research interests are the design and synthesis of probes to explore pathways of biomolecules as well as methodological studies.</p></i></td></tr></table><table><tr><td class="biogPlate"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-p2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-p2.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-p2.gif"/></a><p><span class="graphic_title">Laura Ielo</span></p></td><td><i><p>Laura Ielo graduated <span class="italic">cum laude</span> in Pharmaceutical Chemistry and Technology in 2015 from the University of Messina (Italy) where she also completed her doctoral studies with Prof. De Luca. She received her doctoral degree in 2018 from the University of Messina. She was a visiting PhD student at the University of Vienna (Austria) under the supervision of Prof. Vittorio Pace, where she also conducted her postdoctoral studies. In 2021, she took up an Assistant Professor position at the University of Turin (Italy), and in 2022 obtained the Habilitation for Associate Professor of Organic Chemistry. Her main research activities are focused on the development of new synthetic strategies in homologation reactions with lithium carbenoids and the design and synthesis of biologically active compounds, especially tyrosinase and proteasome inhibitors.</p></i></td></tr></table><hr/>
    
      
      <h2 id="sect307"><span class="a_heading">1. Introduction</span></h2>
      <span>Aziridines are the simplest class of three-membered saturated nitrogen-containing heterocycles. They are less basic than alkylamines but more basic than arylamines. The strain caused by the geometric constraints of the trigonal ring confers high reactivity.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> Indeed, aziridines enable various intriguing synthetic opportunities that can be harnessed. Among these are reactions such as ring-opening, ring enlargement, tandem<a title="Select to navigate to references" href="#cit2"><sup><span class="sup_ref">2</span></sup></a> and multicomponent reactions.<a title="Select to navigate to references" href="#cit3"><sup><span class="sup_ref">3</span></sup></a> In the past, aziridines were considered to be difficult compounds to synthesize due to their instability, which is caused by their reactivity. Nevertheless, a variety of methodologies have been reported for preparing these interesting compounds including catalysis, annulation, and cycloaddition reactions, and organometallic chemistry. Lately, more sustainable conditions have been developed in good agreement with the principles of green chemistry including flow chemistry applications. Furthermore, aziridines are useful building blocks for the preparation of more complex heterocycles or amino acids which are also interesting from biological and pharmacological points of view due to their various biological activities.<a title="Select to navigate to references" href="#cit4"><sup><span class="sup_ref">4</span></sup></a> For these reasons, the interest of the scientific community in these small and fascinating compounds is ever increasing. Therefore, we herein report an overview of the recently developed methodologies regarding the syntheses, synthetic uses, and biological applications of aziridines. We have focused our attention on the past three years, trying to describe the most important breakthroughs that have been made after the publication of other reviews covering this field.<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a></span>
    
    
      
      <h2 id="sect316"><span class="a_heading">2. Preparations of aziridines</span></h2>
      
        
        <h3 id="sect319"><span class="b_heading">2.1 Aziridination of olefins</span></h3>
        <span>Several methodologies have been described for the preparation of aziridine derivatives. Kappe and co-workers reported a continuous flow bromodimethylsulfonium bromide (<strong>2</strong>, BDMS) generation/alkene sulfobromination/aziridination sequence for preparing functionalized aziridines (<strong>4</strong>). BDMS (<strong>2</strong>) is a versatile reagent employed in organic synthesis as a stoichiometric reagent or as a catalyst. However, upon storage, it has to be treated as a hazard since it is corrosive and sensitive to heat and moisture, releasing molecular bromine (Br<small><sub>2</sub></small>) upon contact with water. For this reason, the authors decided to develop a continuous flow procedure for the safe generation and utilization of BDMS (<strong>2</strong>). In addition, by using a flow chemistry approach, the potential hazard from the accumulation of this reagent in batch can be overcome, as the reagent is immediately consumed upon generation. Thus, BDMS (<strong>2</strong>) was prepared for the first time in flow, starting from HBr and DMSO, and was then further reacted with primary amines (<strong>3</strong>) to yield 2-phenyl aziridines (<strong>4</strong>) in a 3-step sequential process (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>).<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s1.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Flow BDMS generation/alkene sulfobromination/aziridination sequence.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Gonnade and co-workers documented the syntheses of aziridine <strong>7</strong> which was then used for the preparation of the well-known Tamiflu (<strong>8</strong>), also called oseltamivir phosphate, which is used as a medicine to cure both influenza A and B and to prevent the spread of influenza. In one of the described procedures, <span class="italic">cis</span>-aziridine (<strong>7</strong>) was employed as a chiral synthon (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>).<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s2.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Aziridination of vinyl bromide <strong>5</strong> for preparing Tamiflu (<strong>8</strong>).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Watson and co-workers reported in 2022 the asymmetric synthesis of aziridines (<strong>13</strong>) <span class="italic">via</span> enantioselective protonation of catalytically generated enamines by using chiral Brønsted acids such as <strong>11</strong> ((<span class="italic">S</span>)-TCYP). The aziridine ring (<strong>13</strong>) is achieved after treating the so-formed α-chloroamine <strong>12</strong> with a base in a one-pot process (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>).<a title="Select to navigate to references" href="#cit8"><sup><span class="sup_ref">8</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch3"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s3.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 3 </b> <span id="sch3"><span class="graphic_title">Asymmetric synthesis of aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Catalysis is one of the most used methodologies for preparing aziridine derivatives. Indeed, a lot of pathways have been described by using different catalysts.<a title="Select to navigate to references" href="#cit9"><sup><span class="sup_ref">9</span></sup></a> Among them, nickel was employed and in 2022 Wu and co-workers reported a nickel-catalyzed aminofluoroalkylative cyclization of unactive alkenes (<strong>15</strong>) with iododifluoromethyl ketones (<strong>14</strong>) to afford versatile difluoroalkylated nitrogen-containing hetorocycles including aziridines (<strong>18</strong>), as shown in <a title="Select to navigate to scheme" href="#imgsch4">Scheme 4</a>.<a title="Select to navigate to references" href="#cit10"><sup><span class="sup_ref">10</span></sup></a> According to the authors, the transformation proceeds through a radical mechanism. Upon treatment with the Ni-catalyst and base, iododifluoromethyl ketones (<strong>14</strong>) are transformed into intermediates such as <strong>16</strong>, which react with <span class="italic">N</span>-allyl anilines (<strong>15</strong>) to give radical species <strong>17</strong>, from which the aziridine products (<strong>18</strong>) are obtained.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch4"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s4.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 4 </b> <span id="sch4"><span class="graphic_title">Nickel catalyzed aziridination of unactive alkenes.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Berhal <span class="italic">et al.</span> documented the iron-catalyzed reaction between alkenes (<strong>20</strong>) and hydroxylamine derivatives (<strong>19</strong>) to give aziridines <strong>22</strong>. In particular, they used simple iron(<span class="small_caps">II</span>) sources and readily available ligands rendering the reaction conditions more sustainable (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5</a>).<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> Considering the mechanism of the reaction, the <span class="italic">in situ</span> generated iron catalyst [Fe] provides an iron–nitrene intermediate (<strong>24</strong> or <strong>25</strong>) after reacting with the hydroxylamine derivative <strong>19</strong>, releasing an equivalent amount of carboxylic acid (<strong>23</strong>). Since metal–nitrene complexes exist in two different spin states, the authors consider two possible reaction pathways. If the metal–nitrene complex predominantly exists in its singlet state (<strong>24</strong>), a concerted (2 + 1) cycloaddition could take place, leading to a stereospecific process (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5</a> – path a). On the other hand, if the iron–nitrene complex is in its triplet state (<strong>25</strong>), a radical addition followed by a radical-based ring closure could occur (<a title="Select to navigate to scheme" href="#imgsch5">Scheme 5</a> – path b). In this case, due to the multistep procedure, no stereoselectivity should be observed.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch5"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s5.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 5 </b> <span id="sch5"><span class="graphic_title">Reaction of alkenes with hydroxylamines for preparing aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Driver <span class="italic">et al.</span> described an intermolecular Rh<small><sub>2</sub></small>(<span class="small_caps">II</span>)-catalyzed aziridination of olefins (<strong>28</strong>) using anilines (<strong>27</strong>) as non-activated nitrogen atom precursors and an iodine(<span class="small_caps">III</span>) reagent (<strong>30</strong>) as the stoichiometric oxidant. During the process, the <span class="italic">N</span>-aryl nitrene fragment is transferred from the intermediate iminoiodinane (<strong>31</strong>) to the Rh(<span class="small_caps">II</span>) carboxylate catalyst <strong>29</strong>. The reaction proved to be stereospecific and chemo- and diastereoselective to produce <span class="italic">N</span>-aryl aziridine <strong>33</strong> as the only amination product (<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>).<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch6"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s6.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 6 </b> <span id="sch6"><span class="graphic_title">Intermolecular Rh<small><sub>2</sub></small>(<span class="small_caps">II</span>)-catalyzed aziridination of olefins.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">After describing in 2022 the use of (NHC)M (M = Cu, Ag, Au) cores as catalysts for the olefin aziridination reaction,<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> recently, Pérez and co-workers reported the copper-catalyzed aziridination of olefins.<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a> The authors highlighted the important role of the halide characterizing the copper catalyst (<a title="Select to navigate to scheme" href="#imgsch7">Scheme 7</a> – path a). Indeed, they demonstrated <span class="italic">via</span> mechanistic studies that the employed copper(<span class="small_caps">I</span>) complexes (TTM)CuCl (<strong>35</strong>) and [(TTM)Cu-(NCMe)]PF<small><sub>6</sub></small> (<strong>36</strong>) (TTM = tris(triazolyl)methane ligand) possess different behaviors, from catalytic and mechanistic points of view, depending on the presence or absence of the chloride ligand bonded to the metal center. If coordination is present, the limiting step of the reaction concerns the formation of the carbon–nitrene bond (<strong>39</strong>). In case the chlorine atom is not present, the highest barrier corresponds to the formation of the copper–nitrene intermediate (<strong>40</strong>). Chen and co-workers selected bis(pyrazolyl)borate Cu(<span class="small_caps">I</span>) complexes (<strong>43</strong>) as catalysts for the aziridination of olefins (<a title="Select to navigate to scheme" href="#imgsch7">Scheme 7</a> – path b). The reaction was carried out starting from a suitable styrene (<strong>41</strong>) and [<span class="italic">N</span>-(sulfonyl)imino]phenyliodinane (<strong>42</strong>). During the catalytic process, a nitrene is generated and added to the double bond.<a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch7"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s7.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 7 </b> <span id="sch7"><span class="graphic_title">Copper-catalyzed olefin aziridination.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Dauban <span class="italic">et al.</span> employed <span class="italic">C</span>4-symmetrical dirhodium(<span class="small_caps">II</span>) tetracarboxylates (<strong>48</strong>) as catalysts for the asymmetric intermolecular aziridination of substituted alkenes (<strong>47</strong>) with <span class="italic">p-t</span>Bu-phenylsulfamates <strong>49</strong> (TBPhsNH<small><sub>2</sub></small>) (<a title="Select to navigate to scheme" href="#imgsch8">Scheme 8</a>). The authors proposed a two-spin-state mechanism, involving a triplet Rh–nitrene species as the key intermediate (<strong>50</strong>) to direct the approach with stereocontrol and for the activation of the substrate. DFT studies support the proposed mechanism. An enantiomeric excess of up to 99% was observed.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch8"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s8.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 8 </b> <span id="sch8"><span class="graphic_title">Asymmetric intermolecular aziridination of substituted alkenes.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Zirconium has also been employed as a catalyst for the synthesis of aziridine derivatives. Moura-Letts and co-workers described the aziridination of alkenes (<strong>41</strong>) by using chloramine T<a title="Select to navigate to references" href="#cit17"><sup><span class="sup_ref">17</span></sup></a> (<strong>52</strong>) as the quantitative source of nitrogen (<a title="Select to navigate to scheme" href="#imgsch9">Scheme 9</a>). Supported by kinetics and model reaction studies, the authors propose that the reaction mechanism involves the formation of a zirconooxaziridine complex (<strong>53</strong>) as the active catalyst.<a title="Select to navigate to references" href="#cit18"><sup><span class="sup_ref">18</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch9"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s9_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s9.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s9.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 9 </b> <span id="sch9"><span class="graphic_title">Zirconium catalyzed synthesis of aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Jat and co-workers reported the iron(<span class="small_caps">II</span>) catalyzed direct N–H/N–Me aziridination of olefins (<strong>55</strong>) employing <span class="italic">O</span>-arylsulfonyl hydroxylamines (<strong>56</strong>). The one-pot methodology proved to be stereo- and regioselective, yielding a variety of unactivated aziridines (<strong>57</strong>) in good to excellent yields (<a title="Select to navigate to scheme" href="#imgsch10">Scheme 10</a>).<a title="Select to navigate to references" href="#cit19"><sup><span class="sup_ref">19</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch10"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s10_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s10.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s10.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 10 </b> <span id="sch10"><span class="graphic_title">Iron(<span class="small_caps">II</span>) catalyzed direct N–H/N–Me aziridination of olefins.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Mixed approaches of photo- and metal-catalysis have also been reported for the synthesis of aziridines.<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a> Koenigs <span class="italic">et al.</span> described the preparation of trifluoromethylated aziridines (<strong>62</strong>) starting from fluorinated olefins (<strong>58</strong>) and iodinanes (<strong>59</strong>), which undergo oxidative quenching in the presence of a Ru(bpy)<small><sub>3</sub></small>Cl<small><sub>2</sub></small> catalyst (<strong>60</strong>), releasing a nitrene radical anion (<strong>61</strong>) (<a title="Select to navigate to scheme" href="#imgsch11">Scheme 11</a>). Computational studies confirmed that the nitrene radical (<strong>61</strong>) serves as a reactive intermediate in direct aziridination reactions.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch11"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s11_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s11.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s11.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 11 </b> <span id="sch11"><span class="graphic_title">Photocatalytic amination reaction for preparing trifluoromethylated aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Zhang and co-workers employed the carbonyl azide TrocN<small><sub>3</sub></small> (<strong>65</strong>, 2,2,2-trichloroethoxycarbonyl azide), which is a potent nitrogen radical precursor for the aziridination of olefins (<strong>64</strong>) <span class="italic">via</span> Co(<span class="small_caps">II</span>)-based metalloradical catalysis (<strong>65</strong>) (<a title="Select to navigate to scheme" href="#imgsch12">Scheme 12</a>). Chiral <span class="italic">N</span>-carbonyl aziridines (<strong>66</strong>) were prepared at room temperature in high yields with excellent enantioselectivities. The obtained <span class="italic">N</span>-Troc-aziridines (<strong>66</strong>) can be opened by different nucleophiles, achieving a variety of chiral amines with excellent stereospecificity (89–100% es).<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch12"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s12_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s12.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s12.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 12 </b> <span id="sch12"><span class="graphic_title">Olefin aziridination <span class="italic">via</span> Co(<span class="small_caps">II</span>)-based metalloradical catalysis.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The major part of the reported methodologies for synthesizing aziridines rely on the transition-metal catalyzed reactions of alkenes with nitrene precursors or imines with carbene precursors.<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> However, these pathways are limited by the use of hazardous and explosive carbene and nitrene precursors as well as additional steps for diazo synthesis and transition-metal residue removal. For these reasons, the development of more sustainable methodologies has been pursued by scientists.<a title="Select to navigate to references" href="#cit24"><sup><span class="sup_ref">24</span></sup></a> Different pathways employing electrochemical activation to facilitate oxidative cyclization were developed.<a title="Select to navigate to references" href="#cit25"><sup><span class="sup_ref">25</span></sup></a> Nevertheless, significant limitations and challenges are still to be overcome. Recently, the employment of thianthrenium salts was reported to be an alternative methodology.<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a> In 2021, Wickens <span class="italic">et al.</span> documented the electrochemical transformation of non-activated alkenes (<strong>67</strong>) into metastable, dicationic intermediates <strong>69</strong> and <strong>70</strong> that undergo aziridination with primary amines (<strong>71</strong>) under basic conditions (<a title="Select to navigate to scheme" href="#imgsch13">Scheme 13</a>). This new approach allows the preparation of diverse aziridine building blocks (<strong>72</strong>) bearing sensitive functional groups, such as allyl and cyano groups, that are challenging to access through more conventional approaches.<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch13"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s13_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s13.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s13.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 13 </b> <span id="sch13"><span class="graphic_title">Electrochemical transformation of unactivated alkenes into aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Shu and co-workers developed a straightforward aziridination pathway using primary amines (<strong>73</strong>) with alkenes substituted with thianthrenes (<strong>74</strong>). The methodology works well for terminal, internal, aromatic, and aliphatic alkenes (<a title="Select to navigate to scheme" href="#imgsch14">Scheme 14</a>).<a title="Select to navigate to references" href="#cit27"><sup><span class="sup_ref">27</span></sup></a> In comparison with the electrochemical thianthrene-mediated aziridine formation, which only allows functionalization of terminal olefins with primary amines<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a> (<a title="Select to navigate to scheme" href="#imgsch13">Scheme 13</a>), this conventional approach allows aziridination of both terminal and internal alkenes. Furthermore it is not limited to the use of primary amines, but also tolerates primary amides, carbamates, and sulfonamides. The use of active methylenes instead leads to cyclopropanation, making the methodology even more versatile.<a title="Select to navigate to references" href="#cit27"><sup><span class="sup_ref">27</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch14"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s14_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s14.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s14.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 14 </b> <span id="sch14"><span class="graphic_title">Aziridination pathway using free primary amines and alkenes substituted with thianthrenes.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The chemoselective aziridination of styrenes (<strong>76</strong>) performed in the presence of hydroxylamine derivatives (<strong>77</strong>) <span class="italic">via</span> cobalt single-atom catalysis was reported by Tang and co-workers in 2023 (<a title="Select to navigate to scheme" href="#imgsch15">Scheme 15</a>). The developed methodology is carried out under mild conditions and has a wide scope and high atom economy. Catalyst <strong>78</strong> is recyclable and not air-sensitive. Several natural products and drug-derived olefins have also been subjected to aziridination.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch15"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s15_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s15.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s15.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 15 </b> <span id="sch15"><span class="graphic_title">Aziridination pathway <span class="italic">via</span> cobalt single atom catalysis.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Díez-González and co-workers reported the preparation of aziridines (<strong>82</strong>) from readily available azides (<strong>80</strong>) and alkenes (<strong>81</strong>). The reaction was carried out without any further additive by using technical solvents without the need for an inert atmosphere as the reaction can proceed in reaction vessels open to air (<a title="Select to navigate to scheme" href="#imgsch16">Scheme 16</a>). The so-prepared aziridines (<strong>82</strong>) were then subjected to ring opening and ring enlargement reactions.<a title="Select to navigate to references" href="#cit29"><sup><span class="sup_ref">29</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch16"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s16_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s16.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s16.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 16 </b> <span id="sch16"><span class="graphic_title">Preparation of aziridines from azides and alkenes.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect541"><span class="b_heading">2.2 Aziridination of imines</span></h3>
        <span>Another common way for synthesizing aziridines is the addition of organometallics or other reagents to imine surrogates or amines.<a title="Select to navigate to references" href="#cit30"><sup><span class="sup_ref">30</span></sup></a> Different methodologies have been reported and some of them allowed the preparation of interesting heterocycles under even more sustainable conditions.<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a></span>
        <p class="otherpara">The presence of fluorine atoms within an organic compound can modulate its physico-chemical properties.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> Therefore, the employment of fluorinated derivatives in medicinal chemistry is very common and the development of new methodologies for the preparation of such interesting molecules is a central topic within the scientific community. In 2021, Njardarson and co-workers described the preparation of trisubstituted trifluoromethylthiolated (SCF<small><sub>3</sub></small>) aziridines (<strong>85</strong>) <span class="italic">via</span> the Darzens pathway. In particular, trisubstituted acetophenone nucleophiles (<strong>83</strong>) bearing SCF<small><sub>3</sub></small> and bromine substituents at the α position undergo reactions with tosyl-protected imines (<strong>84</strong>) under mild conditions to achieve the desired aziridine derivatives (<strong>85</strong>) (<a title="Select to navigate to scheme" href="#imgsch17">Scheme 17</a>).<a title="Select to navigate to references" href="#cit33"><sup><span class="sup_ref">33</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch17"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s17_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s17.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s17.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 17 </b> <span id="sch17"><span class="graphic_title">Preparation of trisubstituted trifluoromethylthiolated (SCF<small><sub>3</sub></small>) aziridines <span class="italic">via</span> the Darzens pathway.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Njandarson and co-workers documented a reaction for preparing aziridines (<strong>88</strong>) starting from benzothiophene 1,1-dioxide (<strong>86</strong>) and imines (<strong>87</strong>). This vinylogous aza-Darzens reaction is base dependent (Cs<small><sub>2</sub></small>CO<small><sub>3</sub></small> is employed) and γ-selective, favouring the formation of <span class="italic">trans</span>-aziridines (<a title="Select to navigate to scheme" href="#imgsch18">Scheme 18</a>).<a title="Select to navigate to references" href="#cit34"><sup><span class="sup_ref">34</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch18"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s18_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s18.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s18.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 18 </b> <span id="sch18"><span class="graphic_title">The aza-Darzens reaction for the preparation of aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">A telescoped reaction for the preparation of aziridines was described by Kürti and co-workers. Various electron-deficient <span class="italic">O</span>-sulfonyl oximes (<strong>90</strong>) were reacted with α,α-disubstituted acetophenone-derived enolates (<strong>89</strong>) to afford highly substituted aziridines (<strong>91</strong>) <span class="italic">via</span> an aza-quasi-Favorskii rearrangement (<a title="Select to navigate to scheme" href="#imgsch19">Scheme 19</a>). This methodology was supported by computational studies which suggested a rearrangement pathway. The reaction of enolate <strong>92</strong> with imine <strong>90</strong> generates the <span class="italic">N</span>-activated β-aminoketone <strong>93</strong> which cyclizes to the <span class="italic">N</span>-activated azetidine <strong>94</strong>. The so-formed azetidine <strong>94</strong> undergoes an aza-quasi-Favorskii rearrangement to yield the highly strained and substituted aziridines <strong>91</strong>.<a title="Select to navigate to references" href="#cit35"><sup><span class="sup_ref">35</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch19"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s19_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s19.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s19.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 19 </b> <span id="sch19"><span class="graphic_title">The aza-quasi-Favorskii rearrangement for the synthesis of aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Pace and co-workers reported an unprecedent homologation reaction <span class="italic">via</span> lithium carbenoids for synthesizing mono- (<strong>96</strong>) and bis-homologated (<strong>97</strong>) trifluoromethyl-aziridine derivatives. The potency of this methodology relies on the selectivity of the reaction. Indeed, just by adjusting the stoichiometry of the employed carbenoid by using either 1.2 or 2.8 equivalents, the authors were able to selectively obtain chloro(trifluoromethyl)- (<strong>96</strong>) or chloromethyl(trifluoromethyl)aziridine derivatives (<strong>97</strong>), respectively.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> A wide scope and full chemocontrol was observed by using LiCH<small><sub>2</sub></small>Cl or LiCH<small><sub>2</sub></small>F as the homologating agent, prepared <span class="italic">via</span> lithium-halogen exchange starting from ICH<small><sub>2</sub></small>Cl or ICH<small><sub>2</sub></small>F and MeLi-LiBr (<a title="Select to navigate to scheme" href="#imgsch20">Scheme 20</a> – path a).<a title="Select to navigate to references" href="#cit37"><sup><span class="sup_ref">37</span></sup></a> Later on, the same group, in collaboration with Luisi and co-workers, described the preparation of rare α-fluoroaziridines (<strong>100</strong>) by using the unknown LiCHFI as the homologating agent. In this case, it was prepared <span class="italic">via</span> lithium-proton exchange (deprotonation) in the presence of the lithium amide base LiN(i-Pr)Cy and ICH<small><sub>2</sub></small>F. After the homologation of the imine derivatives (<strong>98</strong>) with LiCHFI, a series of highly functionalized β-fluoroiodoamines (<strong>99</strong>) were isolated, which were subjected to deprotonation with NaH and after ring closure the desired α-fluoroaziridines (<strong>100</strong>) were achieved (<a title="Select to navigate to scheme" href="#imgsch20">Scheme 20</a> – path b). Only in the case of <strong>102</strong>, the direct formation of the aziridine ring was observed (<a title="Select to navigate to scheme" href="#imgsch20">Scheme 20</a> – path c).<a title="Select to navigate to references" href="#cit38"><sup><span class="sup_ref">38</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch20"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s20_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s20.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s20.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 20 </b> <span id="sch20"><span class="graphic_title">Aziridine preparation <span class="italic">via</span> lithium carbenoids homologations.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2023, Aggarwal and co-workers described a two-step one-pot preparation of spirocyclic aziridines containing a cyclobutane motif. In the initial step, a bicyclo[1.1.0]butyl sulfoxide (<strong>104</strong>) is lithiated and added to a suitable imine (<strong>103</strong>). Afterward, the resulting intermediate (<strong>106</strong>) is cross-coupled with an aryl triflate (<strong>107</strong>) through a C–C σ-bond alkoxy- or aminopalladation, resulting in the related aziridine (<strong>108</strong>) formation (<a title="Select to navigate to scheme" href="#imgsch21">Scheme 21</a>).<a title="Select to navigate to references" href="#cit39"><sup><span class="sup_ref">39</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch21"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s21_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s21.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s21.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 21 </b> <span id="sch21"><span class="graphic_title">Preparation of spirocyclic aziridines containing a cyclobutane motif.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect628"><span class="b_heading">2.3 Miscellaneous intramolecular aziridinations</span></h3>
        <span>In 2021, Luisi <span class="italic">et al.</span> documented a sustainable mixed flow-batch approach for preparing functionalized NH-aziridines (<strong>112</strong>) from vinyl azides (<strong>109</strong>). The first part of the procedure was conducted under continuous flow conditions using CPME (cyclopentyl methyl ether) as the green solvent for obtaining a variety of 2<span class="italic">H</span>-azirines (<strong>110</strong>). Afterwards, the 2<span class="italic">H</span>-azirine (<strong>110</strong>) solution from the microfluidic system was collected in a round bottom flask, cooled to −78 °C and reacted with various lithiated species (<span class="italic">e.g.</span>, phenyllithium, hexyllithium, <span class="italic">n</span>-butyllithium, and i-butyllithium, <strong>111</strong>), affording the desired NH-aziridines (<strong>112</strong>) (<a title="Select to navigate to scheme" href="#imgsch22">Scheme 22</a>).<a title="Select to navigate to references" href="#cit40"><sup><span class="sup_ref">40</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch22"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s22_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s22.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s22.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 22 </b> <span id="sch22"><span class="graphic_title">Mixed flow-batch approach for preparing functionalized NH-aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Gnanaprakasam <span class="italic">et al.</span> described a mixed continuous flow/batch approach for the preparation of spiro-aziridines (<strong>116</strong>). In the first step of the reaction, a variety of spirooxindole 2<span class="italic">H</span>-azirines (<strong>114</strong>) were synthesized <span class="italic">via</span> intramolecular oxidative cyclization of 3-(amino(phenyl)methylene)-indolin-2-one derivatives (<strong>113</strong>) in the presence of I<small><sub>2</sub></small> and Cs<small><sub>2</sub></small>CO<small><sub>3</sub></small>. The so-prepared spirooxindole 2<span class="italic">H</span>-azirines (<strong>114</strong>) were transformed into spiroaziridine derivatives (<strong>116</strong>) <span class="italic">via</span> the addition of Grignard reagents (<strong>115</strong>) (<a title="Select to navigate to scheme" href="#imgsch23">Scheme 23</a>).<a title="Select to navigate to references" href="#cit41"><sup><span class="sup_ref">41</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch23"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s23_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s23.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s23.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 23 </b> <span id="sch23"><span class="graphic_title">Mixed continuous flow/batch approach for preparing aziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Uchiyama <span class="italic">et al.</span> reported the aziridination of <span class="small_caps">L</span>-Val (<strong>117</strong>) by using the non-heme iron enzyme Fe(<span class="small_caps">II</span>)/α-ketoglutarate-dependent oxygenase (<strong>118</strong>, TqaL) as catalyst, <span class="italic">via</span> cyclization proceeding through β-hydrogen abstraction (<a title="Select to navigate to scheme" href="#imgsch24">Scheme 24</a> – path a). This pathway proceeds through an unusual, diverse stereochemical route implying both retention (<strong>121</strong>) and inversion (<strong>122</strong>) of the C3(Cβ) stereocenter.<a title="Select to navigate to references" href="#cit42"><sup><span class="sup_ref">42</span></sup></a> Nishiyama <span class="italic">et al.</span> described the biosynthesis of the aziridine derivative vazabitide A (<strong>125</strong>) catalyzed by Vzb10/11 <span class="italic">via</span> sulfate elimination to give aziridine <strong>124</strong> (<a title="Select to navigate to scheme" href="#imgsch24">Scheme 24</a> – path b). Vazabitide A (<strong>125</strong>) has a similar structure to azinomycin B, which shows antitumoral activity by alkylating the DNA <span class="italic">via</span> aziridine ring opening. Through structural analysis, the authors were able to elucidate the biosynthetic reaction mechanism.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch24"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s24_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s24.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s24.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 24 </b> <span id="sch24"><span class="graphic_title">Aziridination <span class="italic">via</span> biocatalysis.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">With regard to copper-catalyzed aziridine formation, Oestreich <span class="italic">et al.</span> reported in 2023 the preparation of <span class="italic">C</span>-silylated unprotected aziridines (<strong>130</strong>) <span class="italic">via</span> an enantioselective copper-catalyzed (<strong>127</strong>) addition of a silicon nucleophile (<strong>129</strong>) to 3-substituted 2<span class="italic">H</span>-azirines (<strong>126</strong>). They employed an Si–B reagent<a title="Select to navigate to references" href="#cit44"><sup><span class="sup_ref">44</span></sup></a> and in particular, a silyl boronic ester (<strong>129</strong>) as a silicon pronucleophile (<a title="Select to navigate to scheme" href="#imgsch25">Scheme 25</a>).<a title="Select to navigate to references" href="#cit45"><sup><span class="sup_ref">45</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch25"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s25_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s25.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s25.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 25 </b> <span id="sch25"><span class="graphic_title">Preparation of <span class="italic">C</span>-silylated unprotected aziridines <span class="italic">via</span> an enantioselective copper-catalyzed addition.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
    
    
      
      <h2 id="sect705"><span class="a_heading">3. Reactions of aziridines</span></h2>
      
        
        <h3 id="sect708"><span class="b_heading">3.1 Cycloadditions</span></h3>
        <span>Aziridine derivatives are very important substrates and due to their high reactivity, they are largely employed in cycloaddition reactions<a title="Select to navigate to references" href="#cit46"><sup><span class="sup_ref">46</span></sup></a> for the preparation of heterocycles and molecules that are important from a biological point of view.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> Different methodologies have been applied and in recent years, more sustainable conditions have been reported for the preparation of such interesting derivatives.<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a></span>
        <p class="otherpara">Several chiral <span class="italic">trans</span>-substituted imidazolidines (<strong>134</strong>) were synthesized by Feng and co-workers <span class="italic">via</span> the enantioselective reaction of donor–acceptor aziridines (<strong>131</strong>) with <span class="italic">N</span>-aryl protected imines (<strong>132</strong>) using Ni(ClO<small><sub>4</sub></small>)<small><sub>2</sub></small>·6H<small><sub>2</sub></small>O/<span class="italic">N</span>,<span class="italic">N</span>′-dioxide (<strong>133</strong>) as the catalytic system (<a title="Select to navigate to scheme" href="#imgsch26">Scheme 26</a>).<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a> The transformation appears to proceed through transition states such as <strong>135</strong>, where the ring formation starts with the attack from the imine from the <span class="italic">si</span>-face as the <span class="italic">re</span>-face is blocked by the <span class="italic">N</span>-arylsulfonyl moiety. Ring closure occurs subsequently by the attack on the bond that is broken, forming a bond with the carbon bearing the aryl group.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch26"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s26_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s26.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s26.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 26 </b> <span id="sch26"><span class="graphic_title">Enantioselective [3 + 2] cycloaddition of aziridines with <span class="italic">N</span>-aryl protected imines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Usually, the activation of aziridines requires the employment of either a strong Lewis acid or transition metals. Recently, Wang and co-workers described a cycloaddition reaction of a weakly bonded aziridine–selenide complex with non-activated alkenes (<strong>137</strong>) by using phosphonium selenide-based chalcogen bonding catalysts (<strong>138</strong>) (<a title="Select to navigate to scheme" href="#imgsch27">Scheme 27</a> – path a). This study was supported by computational calculation and NMR, demonstrating that an activation mode (<strong>145</strong>) involving the cooperative Se–O and Se–N interactions is involved. The scope of the methodology was extended to alkynes (<strong>141</strong>) (<a title="Select to navigate to scheme" href="#imgsch27">Scheme 27</a> – path b) and ketones (<strong>143</strong>) (<a title="Select to navigate to scheme" href="#imgsch27">Scheme 27</a> – path c).<a title="Select to navigate to references" href="#cit50"><sup><span class="sup_ref">50</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch27"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s27_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s27.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s27.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 27 </b> <span id="sch27"><span class="graphic_title">Cycloaddition of weakly bonded aziridine-selenide complexes with non-activated alkenes (a), alkynes (b), and ketones (c).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect749"><span class="b_heading">3.2 Ring enlargements</span></h3>
        <span>Ring-size manipulation has emerged as a powerful strategy to convert readily available cyclic structures into ring-expanded or ring-contracted compounds, which are more difficult to synthesize. Many methodologies have been described for the preparation of interesting heterocycles starting from aziridines.<a title="Select to navigate to references" href="#cit51"><sup><span class="sup_ref">51</span></sup></a></span>
        <p class="otherpara">Ye <span class="italic">et al.</span> reported in 2020 the synthesis of 4-benzoxazepinones (<strong>150</strong>) <span class="italic">via</span> a <span class="italic">N</span>-heterocyclic carbene/copper co-catalyzed reaction of salicylic aldehydes (<strong>146</strong>) with aziridines (<strong>147</strong>). The applied strategy allowed the authors to obtain compounds of this class, which are also interesting from a pharmaceutical viewpoint, in good yield and with full regioselectivity (<a title="Select to navigate to scheme" href="#imgsch28">Scheme 28</a>).<a title="Select to navigate to references" href="#cit52"><sup><span class="sup_ref">52</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch28"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s28_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s28.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s28.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 28 </b> <span id="sch28"><span class="graphic_title">Synthesis of 4-benzoxazepinones.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The spirooxindole-featuring azacycles have gained interest in the fields of synthetic as well as medicinal chemistry due to their peculiar three-dimensional architecture and interesting biological profiles. In 2022, Hajra and co-workers documented the Brønsted acid- and/or Lewis acid-catalyzed selective C3-allylation of spiro-aziridine oxindoles (<strong>151</strong>) with allyl silanes (<strong>152</strong> and <strong>153</strong>) or allyl Grignard reagents (<strong>154</strong>) to access 3-allyl-3-aminomethyl oxindoles (<strong>155</strong>) and 5-silyl methyl spiro[pyrrolidine-3,3′-oxindoles] (<strong>156</strong>), respectively (<a title="Select to navigate to scheme" href="#imgsch29">Scheme 29</a>).<a title="Select to navigate to references" href="#cit53"><sup><span class="sup_ref">53</span></sup></a> When chiral spiroaziridines were used, the methodology did not show any stereoselectivity. In contrast, the catalyst-free reaction of nonracemic spiroaziridines with allyl-Grignard reagents provided 3-allyl-3-aminomethyl oxindoles (<strong>155</strong>) with good stereoselectivity (ee up to 80%). The pathway was applied for preparing coerulescine (<strong>157</strong>) and various 5′-substituted spiro[pyrrolidine-3,3′-oxindoles] (<strong>156</strong>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch29"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s29_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s29.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s29.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 29 </b> <span id="sch29"><span class="graphic_title">Selective C3-allylation of spiro-aziridine oxindoles with allyl silanes and allyl Grignard reagents.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">A ring enlargement pathway was described as a useful method for the preparation of β-lactams (<strong>160</strong>) by Li and co-workers. They reported a palladium-catalyzed ring expansion reaction of vinyl aziridines (<strong>158</strong>) with commercially available sodium 2-chloro-2,2-difluoroacetate (ClCF<small><sub>2</sub></small>COONa, <strong>159</strong>), which serves as the carbonyl source of a difluorocarbene precursor. The authors reported a difluorocarbene-involved (<strong>161</strong>) reaction of π-allyl Pd(<span class="small_caps">II</span>) complexes (<a title="Select to navigate to scheme" href="#imgsch30">Scheme 30</a> – path a).<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch30"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s30_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s30.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s30.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 30 </b> <span id="sch30"><span class="graphic_title">Ring enlargement pathways for preparing β- and γ-lactams.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2023, Song <span class="italic">et al.</span> synthesized chiral γ-lactams (<strong>167</strong>) through an isothiourea (<strong>166</strong>, ITU)/iridium (<strong>164</strong>) co-catalyzed reaction of vinyl aziridines (<strong>163</strong>) with pentafluorophenyl esters (<strong>162</strong>). This methodology allowed the achievement of several optically active compounds in good yields and with high asymmetric induction (up to 98% ee) (<a title="Select to navigate to scheme" href="#imgsch30">Scheme 30</a> – path b).<a title="Select to navigate to references" href="#cit55"><sup><span class="sup_ref">55</span></sup></a></p>
        <p class="otherpara">Pyridinium 1,4-zwitterionic thiolates (<strong>168</strong>) were employed by Chen and co-workers for the regioselective and stereospecific ring enlargement of aziridines (<strong>169</strong>). 3,4-Dihydro-2<span class="italic">H</span>-1,4-thiazines (<strong>170</strong> and <strong>171</strong>) were prepared <span class="italic">via</span> a domino S<small><sub>N</sub></small>2 ring-opening/<span class="italic">N</span>-Michael addition cyclization/retro-Michael addition/pyridine extrusion procedure under mild conditions without metal mediation or the need for a strong base (<a title="Select to navigate to scheme" href="#imgsch31">Scheme 31</a>).<a title="Select to navigate to references" href="#cit108"><sup><span class="sup_ref">108</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch31"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s31_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s31.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s31.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 31 </b> <span id="sch31"><span class="graphic_title">Ring enlargement of aziridines with pyridinium 1,4-zwitterionic thiolates.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Unprotected guanidine derivatives (<strong>176</strong> and <strong>177</strong>) were prepared <span class="italic">via</span> ring expansion of 2-substituted aziridines (<strong>172</strong>) and <span class="italic">N</span>-tosyl cyanamides (<strong>173</strong>) in a domino regioselective ring-opening/5-<span class="italic">exo-dig</span> cyclization. This metal-free methodology works well even with weaker bases such as cesium fluoride (CsF). Furthermore, the so-obtained compounds could be subjected to hydrolysis in order to obtain highly biologically interesting urea analogs (<strong>178</strong> and <strong>179</strong>) (<a title="Select to navigate to scheme" href="#imgsch32">Scheme 32</a>).<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch32"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s32_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s32.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s32.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 32 </b> <span id="sch32"><span class="graphic_title">Aziridine ring enlargements for preparing unprotected guanidine derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Schomaker <span class="italic">et al.</span> reported a [3 + 3] ring expansion of bicyclic aziridines (<strong>180</strong>) and rhodium-bound vinyl carbenes to synthesize a variety of dehydropiperidines (<strong>184</strong>). Supported by mechanistic studies, the authors supposed that the pathway proceeds <span class="italic">via</span> the formation of a vinyl aziridinium ylide (<strong>183</strong>) which undergoes a pseudo-[1,4]-sigmatropic rearrangement to yield heterocyclic products (<strong>184</strong>) with net retention of the configuration at the new CC bond (<a title="Select to navigate to scheme" href="#imgsch33">Scheme 33</a>).<a title="Select to navigate to references" href="#cit57"><sup><span class="sup_ref">57</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch33"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s33_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s33.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s33.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 33 </b> <span id="sch33"><span class="graphic_title">Preparation of dehydropiperidines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Feng <span class="italic">et al.</span> documented the ring enlargement of racemic donor–acceptor (D–A) aziridines (<strong>185</strong>) with isocyanides (<strong>186</strong>) catalyzed by a chiral <span class="italic">N</span>,<span class="italic">N</span>-dioxide (<strong>187</strong>)/Mg(<span class="small_caps">II</span>) complex, proceeding through ring opening <span class="italic">via</span> intermediates, such as <strong>188</strong>, to yield enantioenriched <span class="italic">exo</span>-imido azetidines (<strong>189</strong>) (<a title="Select to navigate to scheme" href="#imgsch34">Scheme 34</a>).<a title="Select to navigate to references" href="#cit109"><sup><span class="sup_ref">109</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch34"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s34_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s34.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s34.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 34 </b> <span id="sch34"><span class="graphic_title">Exo-imido azetidine preparation.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The preparation of 2-(2-oxoalkylidene)-1,3-oxazolidine derivatives (<strong>193</strong>) was described by Xu and co-workers in 2021 <span class="italic">via</span> the catalyst-free electrophilic ring expansion of <span class="italic">N</span>-unprotected aziridines (<strong>191</strong>) and the ketene C<img class="charmap" src="https://www.rsc.org/images/entities/char_e001.gif" alt="[double bond, length as m-dash]"/>O double bond of α-oxoketenes (<strong>192</strong>).<a title="Select to navigate to references" href="#cit58"><sup><span class="sup_ref">58</span></sup></a> Products <strong>192</strong> were prepared <span class="italic">in situ</span> through microwave-assisted Wolff rearrangement of 2-diazo-1,3-diketones (<strong>190</strong>) (<a title="Select to navigate to scheme" href="#imgsch35">Scheme 35</a>). Products <strong>193</strong> were obtained with an <span class="italic">E</span> configuration <span class="italic">via</span> an S<small><sub>N</sub></small>1 mechanism.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch35"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s35_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s35.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s35.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 35 </b> <span id="sch35"><span class="graphic_title">Catalyst-free ring expansion of <span class="italic">N</span>-unprotected aziridines for preparing 2-(2-oxoalkylidene)-1,3-oxazolidine derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Alkoxycarbonylketenes (<strong>196</strong>), generated from alkyl 2-diazo-3-oxoalkanoates (<strong>194</strong>), were employed as substrates for the electrophilic ring expansion of aziridines (<strong>195</strong>) in order to obtain alkyl 2-(oxazolin-2-yl)alkanoates (<strong>197</strong>) under microwave irradiation.<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> The corresponding final compounds (<strong>197</strong>) were obtained in good yields; in all cases, the formation of 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 mixtures of diastereomeric products was observed (<a title="Select to navigate to scheme" href="#imgsch36">Scheme 36</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch36"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s36_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s36.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s36.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 36 </b> <span id="sch36"><span class="graphic_title">Microwave-assisted ring expansion of aziridines to obtain alkyl 2-(oxazolin-2-yl)alkanoates.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Arnold and co-workers documented the biocatalytic enantioselective one-carbon ring expansion of aziridines (<strong>198</strong>) to yield azetidines (<strong>202</strong>) <span class="italic">via</span> [1,2]-Stevens rearrangement by using “carbene transferase” as enzymes (<a title="Select to navigate to scheme" href="#imgsch37">Scheme 37</a>). The employment of biocatalysts was crucial for controlling the reactivity of the formed aziridinium ylide intermediates (<strong>201</strong>), which could be not controlled by using other catalyst classes.<a title="Select to navigate to references" href="#cit60"><sup><span class="sup_ref">60</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch37"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s37_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s37.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s37.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 37 </b> <span id="sch37"><span class="graphic_title">Azetidines from aziridines <span class="italic">via</span> ring enlargement.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">A typical ring enlargement reaction concerning aziridines is the one with CO<small><sub>2</sub></small> (<strong>204</strong>).<a title="Select to navigate to references" href="#cit61"><sup><span class="sup_ref">61</span></sup></a> Indeed, different methodologies were described by using diverse catalysts.<a title="Select to navigate to references" href="#cit62"><sup><span class="sup_ref">62</span></sup></a> Among them, Caselli and co-workers reported the preparation of 5-substituted 1,3-oxazolidin-2-ones (<strong>206</strong>) catalysed by ammonium ferrates (<strong>205</strong>) (<a title="Select to navigate to scheme" href="#imgsch38">Scheme 38</a> – path a). Theoretical calculations clarified that the reaction mechanism involves just one ferrate molecule and the rate determining step is the 1,3-oxazolidin-2-one ring closure.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> Zhao and co-workers documented the reaction of CO<small><sub>2</sub></small> (<strong>204</strong>) and aziridines (<strong>207</strong>) catalyzed by MOFs (metal–organic frameworks). In particular, they prepared three-dimensional cluster-based MOF {(NH<small><sub>2</sub></small>Me<small><sub>2</sub></small>)[Co<small><sub>3</sub></small>(μ<small><sub>3</sub></small>-OH)(BTB)<small><sub>2</sub></small>(H<small><sub>2</sub></small>O)]·9H<small><sub>2</sub></small>O·5DMF}<small><sub><span class="italic">n</span></sub></small> (<strong>208</strong>) with large pores assembled by BTB ligands (<strong>209</strong>, BTB = 1,3,5-tri(4-carboxyphenyl)benzene) and [Co<small><sub>3</sub></small>] clusters (<a title="Select to navigate to scheme" href="#imgsch38">Scheme 38</a> – path b). With this methodology they achieved oxazolidinones (<strong>210</strong> and <strong>211</strong>) in up to 99% yield.<a title="Select to navigate to references" href="#cit64"><sup><span class="sup_ref">64</span></sup></a> Recently, Venkatasubbaiah <span class="italic">et al.</span> described the solvent-free reaction of aziridines (<strong>212</strong>) and carbon dioxide (<strong>204</strong>), catalyzed by a zinc-salen having a B–N coordinated phenanthroimidazole motif (<strong>213</strong>) as a photocatalyst, for the synthesis of oxazolidinones (<strong>214</strong>) (<a title="Select to navigate to scheme" href="#imgsch38">Scheme 38</a> – path c).<a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch38"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s38_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s38.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s38.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 38 </b> <span id="sch38"><span class="graphic_title">Ring enlargement by the reaction of CO<small><sub>2</sub></small> and aziridines for preparing oxazolidinones.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Schomaker <span class="italic">et al.</span> described a Rh catalyzed ring expansion of aziridines (<strong>215</strong>) and <span class="italic">N</span>-sulfonyl-1,2,3-triazoles (<strong>216</strong>). Instead of the expected dehydropiperazines (<strong>218</strong>), the authors observed the formation of [3,9]-bicyclic aziridines (<strong>217</strong>), see <a title="Select to navigate to scheme" href="#imgsch39">Scheme 39</a>. The structure was confirmed by computational calculation and X-ray studies.<a title="Select to navigate to references" href="#cit66"><sup><span class="sup_ref">66</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch39"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s39_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s39.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s39.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 39 </b> <span id="sch39"><span class="graphic_title">Rh catalyzed ring expansion of aziridines and <span class="italic">N</span>-sulfonyl-1,2,3-triazoles.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">A one-pot reaction for preparing benzooxepino-fused pyrrole derivatives (<strong>221</strong>) starting from substituted alkynyl aziridines (<strong>219</strong>) was reported by Sridhar and co-workers. In this metal-free procedure, two new CC bonds were established <span class="italic">via</span> the initial cleavage of the CC bond of the aziridine ring by the <span class="italic">in situ</span> generated azomethine ylides (<strong>220</strong>) (<a title="Select to navigate to scheme" href="#imgsch40">Scheme 40</a>).<a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch40"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s40_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s40.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s40.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 40 </b> <span id="sch40"><span class="graphic_title">Preparation of benzooxepino-fused pyrrole derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect951"><span class="b_heading">3.3 Ring openings</span></h3>
        <span>Ring opening reactions are amongst the most important synthetic pathways of aziridines<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> as they can be transformed into many interesting compounds such as amino acids and natural products<a title="Select to navigate to references" href="#cit69"><sup><span class="sup_ref">69</span></sup></a> that are very often useful for pharmacological applications.</span>
        <p class="otherpara">Various <span class="italic">N</span>-(2,2-diphenylvinyl)-β-oxoamides (<strong>225</strong>) were prepared by Xu and co-workers, <span class="italic">via</span> a microwave-assisted catalyst-free methodology, starting from 2-diazo-1,3-dicarbonyl compounds (<strong>222</strong>) through an electrophilic ring opening of <span class="italic">N</span>-alkyl-2,2-diphenylaziridines (<strong>223</strong>).<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> α-Oxoketenes (<strong>224</strong>), which then reacted with aziridines <strong>223</strong>, were generated from 2-diazo-1,3-dicarbonyl derivatives (<strong>222</strong>) <span class="italic">via</span> a Wolff rearrangement (<a title="Select to navigate to scheme" href="#imgsch41">Scheme 41</a>). The so-obtained <span class="italic">N</span>-(2,2-diphenylvinyl)-β-oxoamides (<strong>225</strong>) are useful molecules as synthons for the preparation of β-lactams but also common structural motifs in biologically active compounds.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch41"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s41_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s41.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s41.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 41 </b> <span id="sch41"><span class="graphic_title">
            <span class="italic">N</span>-(2,2-Diphenylvinyl)-β-oxoamide generation from 2-diazo-1,3-dicarbonyl compounds and <span class="italic">N</span>-alkyl-2,2-diphenylaziridines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Zhu and co-workers reported the synthesis of 4-spiroannulated tetrahydroisoquinolines (<strong>228</strong>) <span class="italic">via</span> a multistep procedure involving a sequential ring opening of aziridines <strong>226</strong> and the subsequent Pictet–Spengler reaction.<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a> The reaction proceeds under mild conditions with a broad scope. Considering the reaction mechanism, the TBS group is eliminated from derivative <strong>229</strong> by treatment with TBAF and the so-obtained free OH group (<strong>230</strong>) promoted an internal aziridine ring opening. The newly formed intermediate <strong>231</strong> reacted with formaldehyde (<strong>227</strong>) under acidic conditions to generate the iminium ion <strong>232</strong>, which undergoes electrophilic cyclization to afford the final product <strong>233</strong> (<a title="Select to navigate to scheme" href="#imgsch42">Scheme 42</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch42"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s42_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s42.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s42.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 42 </b> <span id="sch42"><span class="graphic_title">Synthesis of 4-spiroannulated tetrahydroisoquinolines <span class="italic">via</span> a sequential ring opening of aziridines and the Pictet–Spengler reaction.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">
          <span class="italic">C</span>-Glycosyl-aminoethyl sulfide derivatives (<strong>246–249</strong>) were synthesized by Zawisza <span class="italic">et al. via</span> a reaction between tributyltin derivatives of glycals (<strong>234–235</strong>) and aziridinecarbaldehyde (<strong>236</strong>) and the regioselective ring opening of chiral aziridines (<strong>241–244</strong>) with thiophenol (<strong>245</strong>) (<a title="Select to navigate to scheme" href="#imgsch43">Scheme 43</a>).<a title="Select to navigate to references" href="#cit72"><sup><span class="sup_ref">72</span></sup></a> Glycoconjugates are very interesting derivatives due to their participation in many important biochemical processes.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch43"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s43_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s43.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s43.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 43 </b> <span id="sch43"><span class="graphic_title">Preparation of <span class="italic">C</span>-glycosyl-aminoethyl sulfide derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Tang <span class="italic">et al.</span> described a methodology for the preparation of β-trifluoromethoxylated amines (<strong>252</strong>). This fascinating class of compounds was achieved <span class="italic">via</span> a silver-catalyzed ring opening of tosyl-aziridines (<strong>250</strong>) in the presence of trifluoromethyl arylsulfonate (<strong>251</strong>) (<a title="Select to navigate to scheme" href="#imgsch44">Scheme 44</a> – path a). A good chemo- and regioselectivity was observed under mild conditions.<a title="Select to navigate to references" href="#cit110"><sup><span class="sup_ref">110</span></sup></a> The same group accessed a series of β-trifluoromethylthiolated isothiocyanates (<strong>253</strong>) and amines (<strong>254</strong>) by using AgSCF<small><sub>3</sub></small> and different iodine sources (TBAI, KI) (<a title="Select to navigate to scheme" href="#imgsch44">Scheme 44</a> – path b).<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch44"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s44_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s44.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s44.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 44 </b> <span id="sch44"><span class="graphic_title">Silver-catalyzed aziridine ring opening.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In 2022, Doyle and co-workers reported an aziridine ring opening procedure with methyl/1°/2° aliphatic alcohols activated as benzaldehyde dialkyl acetals (<strong>256</strong>) <span class="italic">via</span> a Ni/photoredox cross-coupling.<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> The activation of the benzaldehyde dialkyl acetal (<strong>256</strong>) is carried out through hydrogen atom abstraction and β-scission <span class="italic">via</span> a bromine radical. The authors demonstrated that aziridine activation proceeds through oxidative addition to Ni(<span class="small_caps">I</span>) rather than a Ni(<span class="small_caps">II</span>)azametallacycle, as reported previously (<a title="Select to navigate to scheme" href="#imgsch45">Scheme 45</a>).<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch45"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s45_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s45.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s45.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 45 </b> <span id="sch45"><span class="graphic_title">Aziridines ring opening <span class="italic">via</span> a Ni/photoredox cross-coupling.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Palladium is the catalyst employed by Zhou and co-workers in a three-component Catellani reaction<a title="Select to navigate to references" href="#cit76"><sup><span class="sup_ref">76</span></sup></a> starting from aryl iodides (<strong>260</strong>), typically for Catellani reactions with substituents at the <span class="italic">ortho</span>-position, aziridines (<strong>261</strong>), and (triisopropylsilyl)acetylene (<strong>262</strong>) as the building blocks. This first step of the reaction was useful for the preparation of the 2′-alkynylaryl-2-ethylamines (<strong>265</strong>), which were further reacted <span class="italic">via</span> a multistep procedure for preparing 1,3-<span class="italic">trans</span>-disubstituted tetrahydroisoquinolines <strong>266</strong> (THIQ), which is important from a biological point of view (<a title="Select to navigate to scheme" href="#imgsch46">Scheme 46</a>).<a title="Select to navigate to references" href="#cit77"><sup><span class="sup_ref">77</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch46"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s46_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s46.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s46.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 46 </b> <span id="sch46"><span class="graphic_title">Synthesis of 1,3-<span class="italic">trans</span>-disubstituted tetrahydroisoquinolines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Han <span class="italic">et al.</span> instead documented the copper-catalyzed regioselective and stereospecific ring opening of aziridines with pyrydinyl Grignard nucleophiles. With this methodology, the preparation of β-pyridylethylamines (<strong>269</strong>) was achieved, which are potential scaffolds for the synthesis of biologically active molecules. Challenging chiral dihydroazaindoles (<strong>270</strong>) were prepared <span class="italic">via</span> a mild one-pot aziridine opening followed by nucleophilic cyclization (<a title="Select to navigate to scheme" href="#imgsch47">Scheme 47</a>).<a title="Select to navigate to references" href="#cit78"><sup><span class="sup_ref">78</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch47"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s47_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s47.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s47.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 47 </b> <span id="sch47"><span class="graphic_title">Aziridine ring opening with pyridyl Grignard nucleophiles.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Hayla and co-workers described a catalyst-free regioselective ring-opening of aziridines (<strong>274</strong>), including spiroaziridine oxindoles (<strong>271</strong>), with commercially available 50% aqueous hydrogen peroxide (<strong>272</strong>). The reaction, which can be carried out without any additional organic solvents and reagents, gives rise to secondary benzylic β-hydroperoxy amines (<strong>275</strong>) and tertiary 3-hydroperoxy oxindoles (<strong>273</strong>) (<a title="Select to navigate to scheme" href="#imgsch48">Scheme 48</a>).<a title="Select to navigate to references" href="#cit79"><sup><span class="sup_ref">79</span></sup></a> The importance of this methodology relies on the utility of organic hydroperoxides, which are prevalent motifs in various biosynthetic intermediates, natural products, and bioactive compounds.<a title="Select to navigate to references" href="#cit80"><sup><span class="sup_ref">80</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch48"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s48_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s48.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s48.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 48 </b> <span id="sch48"><span class="graphic_title">Aziridine ring opening by using 50% aqueous H<small><sub>2</sub></small>O<small><sub>2</sub></small>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Hou <span class="italic">et al.</span> reported the ring opening of diastereomerically pure 2-oxazolidinone-fused aziridines (<strong>276</strong>) <span class="italic">via</span> fluoride anions. This methodology allows the preparation of optically active, primary, secondary, and tertiary organofluorides (<strong>277</strong>), which are precursors of interesting compounds such as fluorinated amino acids (<a title="Select to navigate to scheme" href="#imgsch49">Scheme 49</a>).<a title="Select to navigate to references" href="#cit81"><sup><span class="sup_ref">81</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch49"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s49_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s49.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s49.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 49 </b> <span id="sch49"><span class="graphic_title">Ring opening of 2-oxazolidinone-fused aziridines <span class="italic">via</span> a fluoride anion.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect1079"><span class="b_heading">3.4 Catalysis</span></h3>
        <span>Most drugs are small molecules featuring heterocycles; therefore, they are ubiquitous in medicinal chemistry. Among them, indole derivatives are common scaffolds used for the design of plausible “drug-like” compounds. For these reasons, scientists around the world have put in efforts for the development of novel methodologies that can be useful for preparing and modifying these heterocyclic compounds. Koley and co-workers reported in 2022 a palladium catalyzed cross-coupling of aliphatic aziridines (<strong>279</strong> and <strong>282</strong>) with indoles (<strong>278</strong>), indolines, tetrahydroquinolines, and anilines (<strong>281</strong>) for preparing β-arylethylamine derivatives (<strong>280</strong> and <strong>283</strong>) with a wide scope (<a title="Select to navigate to scheme" href="#imgsch50">Scheme 50</a>).<a title="Select to navigate to references" href="#cit82"><sup><span class="sup_ref">82</span></sup></a> These transformations proceed <span class="italic">via</span> CH activation.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch50"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s50_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s50.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s50.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 50 </b> <span id="sch50"><span class="graphic_title">Preparation of β-arylethylamine derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Another important aspect is the preparation of amino acid derivatives from aziridine substrates. In recent years, the synthesis of functional quaternary amino acid derivatives has attracted considerable attention since they are key components in many active pharmaceutical ingredients. Among them, in 2022, Gao and co-workers reported the preparation of functionalized precursors of quaternary allylic amino acids(<strong>287</strong>) <span class="italic">via</span> a palladium-catalyzed allylic alkylation reaction of azalactones (<strong>284</strong>) with vinyl aziridine (<strong>285</strong>) (<a title="Select to navigate to scheme" href="#imgsch51">Scheme 51</a>).<a title="Select to navigate to references" href="#cit83"><sup><span class="sup_ref">83</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch51"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s51_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s51.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s51.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 51 </b> <span id="sch51"><span class="graphic_title">Preparation of functionalized quaternary allylic amino acid precursors.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The preparation of chiral pyridine-oxazolines (<strong>290</strong>) starting from (<span class="italic">meso</span>)-<span class="italic">N</span>-(2-picolinoyl)-aziridines (<strong>288</strong>) catalyzed by a chiral ytterbium(<span class="small_caps">III</span>)-<span class="italic">N</span>,<span class="italic">N</span>′-dioxide (<strong>289</strong>) complex was reported by Liu and Feng in 2022. The reaction proceeds <span class="italic">via</span> an asymmetric Heine reaction, giving excellent yields with very good enantioselectivities (<a title="Select to navigate to scheme" href="#imgsch52">Scheme 52</a>).<a title="Select to navigate to references" href="#cit84"><sup><span class="sup_ref">84</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch52"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s52_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s52.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s52.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 52 </b> <span id="sch52"><span class="graphic_title">Ytterbium catalyzed synthesis of chiral pyridine-oxazolines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Martin and co-workers reported a nickel-catalyzed reductive carboxylation of <span class="italic">N</span>-substituted aziridines (<strong>291</strong>) with CO<small><sub>2</sub></small> (<strong>204</strong>) at atmospheric pressure for accessing β-amino acids (<strong>293</strong>) (<a title="Select to navigate to scheme" href="#imgsch53">Scheme 53</a> – path a). The procedure works under mild conditions and exhibits high chemo- and regioselectivity.<a title="Select to navigate to references" href="#cit85"><sup><span class="sup_ref">85</span></sup></a> Wang <span class="italic">et al.</span> applied a combined nickel/photoco-catalyzed hydrogen-atom-transfer in order to achieve the ring opening of <span class="italic">N</span>-tosyl styrenyl aziridines (<strong>295</strong>) with aldehydes (<strong>294</strong>). This method is a novel and atom-economical synthetic path towards a variety of β-amino ketones (<strong>297</strong>) with complete regiocontrol (<a title="Select to navigate to scheme" href="#imgsch53">Scheme 53</a> – path b). With this strategy, the difficult coupling between aldehydes and aziridines, which are both electrophilic species, can be facilitated.<a title="Select to navigate to references" href="#cit86"><sup><span class="sup_ref">86</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch53"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s53_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s53.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s53.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 53 </b> <span id="sch53"><span class="graphic_title">Nickel-catalyzed preparation of β-amino acids.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Anderson and co-workers described the preparation of 1,3-disubstituted bicyclo[1.1.1]pentylamines (<strong>302</strong>, BCPAs) based on a radical functionalization strategy. In particular, sulfonamidyl radicals, obtained <span class="italic">via</span> α-iodoaziridine (<strong>298</strong>) fragmentation, undergo initial addition with [1.1.1]propellane (<strong>299</strong>) to afford iodo-BCPAs (<strong>300</strong>). Afterwards, the so-formed CI bond is functionalized <span class="italic">via</span> a silyl-mediated Giese reaction (<a title="Select to navigate to scheme" href="#imgsch54">Scheme 54</a> – path a).<a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a> Xu <span class="italic">et al.</span> reported a radical addition/elimination strategy for preparing fluorinated allenes (<strong>305</strong>) starting from fluoroalkyl halides (<strong>304</strong> and <strong>306</strong>) and alkynyl aziridines (<strong>303</strong>) under visible-light irradiation (<a title="Select to navigate to scheme" href="#imgsch54">Scheme 54</a> – path b).<a title="Select to navigate to references" href="#cit88"><sup><span class="sup_ref">88</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch54"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s54_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s54.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s54.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 54 </b> <span id="sch54"><span class="graphic_title">Preparation of 1,3-disubstituted bicyclo[1.1.1]pentylamines.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Recently, the ring formation by the reaction of tosyl-aziridines (<strong>308</strong>) and indole derivatives (<strong>307</strong>) <span class="italic">via</span> [Cp*RhCl<small><sub>2</sub></small>]<small><sub>2</sub></small> catalysis (<strong>309</strong>) was described by Zhu and co-workers. A series of <span class="italic">cis</span>-1,4-disubstitued tetrahydro-γ-carbolines (<strong>312</strong>) was formed in high yields and excellent <span class="italic">cis</span>-diastereoselectivity under mild conditions. The authors postulated a stepwise mechanism, proceeding through the rhodacyclic intermediate <strong>310</strong>, which undergoes ring opening upon coordination of silver phosphate with nitrogen. The resulting intermediate <strong>311</strong> undergoes Michael addition to form a six-membered ring (<a title="Select to navigate to scheme" href="#imgsch55">Scheme 55</a>).<a title="Select to navigate to references" href="#cit89"><sup><span class="sup_ref">89</span></sup></a> According to the authors, only the formations of the <span class="italic">cis</span>-1,4-diastereomers was observed.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch55"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s55_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s55.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s55.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 55 </b> <span id="sch55"><span class="graphic_title">Preparation of <span class="italic">cis</span>-1,4-disubstitued tetrahydro-γ-carbolines from aziridines and 3-vinyl indoles substituted with EWGs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
    
    
      
      <h2 id="sect1170"><span class="a_heading">4. Aziridines as reaction intermediates and catalysts</span></h2>
      <span>Aziridines are very interesting reactions intermediates. Due to the ring strain, they are highly reactive and largely employed in multi-step reactions. Aziridines are useful for the preparation of fascinating organic compounds as well as for the synthesis of biologically active molecules.<a title="Select to navigate to references" href="#cit90"><sup><span class="sup_ref">90</span></sup></a></span>
      <p class="otherpara">In 2021, Pelletier <span class="italic">et al.</span> documented the synthesis of imidazo-[1,2-<span class="italic">a</span>]pyridines (<strong>317</strong>) by using 2-chloropyridines (<strong>313</strong>) and 2<span class="italic">H</span>-azirines (<strong>314</strong>) in the presence of triflic anhydride (<strong>315</strong>, Tf<small><sub>2</sub></small>O). An electrophilic 1-trifloyl-aziridin-2-yl triflate species is formed as the reaction intermediate which reacts <span class="italic">in situ</span> with the 2-halopyridines, forming transient pyridinium salts (<strong>316</strong>). These salts were treated in the same pot with triethylamine (Et<small><sub>3</sub></small>N), leading to the selective formation of the desired compounds (<strong>317</strong>) (<a title="Select to navigate to scheme" href="#imgsch56">Scheme 56</a>).<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch56"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s56_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s56.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s56.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 56 </b> <span id="sch56"><span class="graphic_title">Aziridines used as intermediates.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Another interesting example that highlights the use of aziridines as intermediates was reported in 2022 by Powers and co-workers. The authors described an olefin aziridination procedure by employing <span class="italic">N</span>-aminopyridinium reagents (<strong>319</strong>) as the activating group to afford <span class="italic">N</span>-pyridinium aziridines (<strong>320</strong>). The so-formed aziridines (<strong>320</strong>) then were subjected to a nickel-catalyzed C–N cross-coupling reaction with aryl boronic acids (<strong>321</strong>). The <span class="italic">N</span>-pyridinium aziridine intermediates (<strong>320</strong>) also participate in ring-opening chemistry with different nucleophiles to achieve 1,2-aminofunctionalization products. Mechanistic studies denote that the aziridine cross-coupling proceeds <span class="italic">via</span> a noncanonical mechanism involving initial aziridine opening (<strong>322</strong>), promoted by the bromide counterion of the nickel catalyst, and finally the formation of the aziridine moiety (<strong>323</strong>) by a ring-closing step (<a title="Select to navigate to scheme" href="#imgsch57">Scheme 57</a>).<a title="Select to navigate to references" href="#cit92"><sup><span class="sup_ref">92</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch57"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s57_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s57.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s57.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 57 </b> <span id="sch57"><span class="graphic_title">Aziridinations of alkenes and nickel-catalyzed cross-coupling.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">In 2023, Bower and co-workers reported the preparation of stereochemically complex polyheterocyclic ring systems (<strong>327</strong>) <span class="italic">via</span> an aziridine intermediate (<strong>326</strong>). In particular, an intramolecular stereospecific aza-Prilezhaev aziridination occurs which is followed by a CN bond cleavage operated by a pendant nucleophile (<a title="Select to navigate to scheme" href="#imgsch58">Scheme 58</a>). With this methodology, a variety of alkene <span class="italic">anti</span>-1,2-difunctionalizations (<span class="italic">i.e.</span>, diaminations, amino-oxygenations and amino-arylations) can be facilitated. The majority of the obtained structures are relevant in medicinal chemistry.<a title="Select to navigate to references" href="#cit93"><sup><span class="sup_ref">93</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch58"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s58_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s58.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s58.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 58 </b> <span id="sch58"><span class="graphic_title">Preparation of stereochemically complex polyheterocycles.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Luisi <span class="italic">et al.</span> employed aziridines as chiral nucleophiles in the enantioselective synthesis of oxaspirohexane sulfonamide derivatives (<strong>338</strong>). In particular, (<span class="italic">S</span>)-<span class="italic">N-t</span>-butylsulfonyl-2-phenylaziridine (<strong>333</strong>) was prepared starting from (<span class="italic">S</span>)-phenyl-glycinol (<strong>332</strong>). The lithiated intermediate <strong>334</strong> was trapped with 3-phenylcyclobutanone (<strong>331</strong>) to give a 90<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>10 <span class="italic">cis</span>/<span class="italic">trans</span> diastereomeric mixture of aziridino cyclobutanol (<strong>335</strong> and <strong>336</strong>). The <span class="italic">cis</span>-stereoisomer underwent Payne rearrangement under basic conditions, leading to the desired 1-azaspiro[2,3]hexane (<strong>338</strong>) (<a title="Select to navigate to scheme" href="#imgsch59">Scheme 59</a>).<a title="Select to navigate to references" href="#cit94"><sup><span class="sup_ref">94</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch59"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s59_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s59.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s59.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 59 </b> <span id="sch59"><span class="graphic_title">Synthesis of oxaspirohexane sulfonamide derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Aziridines were also reported to be useful catalysts.<a title="Select to navigate to references" href="#cit95"><sup><span class="sup_ref">95</span></sup></a> Rachwalski and co-workers described an asymmetric Morita–Baylis–Hillman reaction of methyl vinyl ketone and methyl acrylate (<strong>339</strong>) with various aromatic aldehydes (<strong>340</strong>) using chiral aziridine-phosphines (<strong>341</strong>) as chiral catalysts (<a title="Select to navigate to scheme" href="#imgsch60">Scheme 60</a>).<a title="Select to navigate to references" href="#cit96"><sup><span class="sup_ref">96</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch60"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-s60_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-s60.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-s60.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 60 </b> <span id="sch60"><span class="graphic_title">Chiral aziridines as chiral catalysts.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect1247"><span class="a_heading">5. Biological activities of aziridines</span></h2>
      <span>Aziridine derivatives possess different biological activities. Among them a large variety of compounds are active against various types of oncological diseases.<a title="Select to navigate to references" href="#cit97"><sup><span class="sup_ref">97</span></sup></a> However, several molecules displayed inhibitory activity towards other biological targets such proving to be good glucocerebrosidase (GBA),<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a> cysteine proteases,<a title="Select to navigate to references" href="#cit99"><sup><span class="sup_ref">99</span></sup></a> tuberculosis,<a title="Select to navigate to references" href="#cit100"><sup><span class="sup_ref">100</span></sup></a> microbial,<a title="Select to navigate to references" href="#cit101"><sup><span class="sup_ref">101</span></sup></a> and <span class="italic">Leishmania</span><a title="Select to navigate to references" href="#cit102"><sup><span class="sup_ref">102</span></sup></a> inhibitors (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-f1.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Biological activity of aziridine derivatives.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
        
        <h3 id="sect1261"><span class="b_heading">5.1 Aziridines showing activity against GBA</span></h3>
        <span>Kuo and co-workers discovered a series of cyclophellitol aziridine derivatives as promising selective GBA inhibitors. Genetic defects in GBA determine Gaucher disease (GD) and also represent a risk factor for developing Parkinson's disease. One of the most active compound of the series is derivative <strong>343</strong> with an IC<small><sub>50</sub></small> value of 1.20 nM on human GBA (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a></span>
      
      
        
        <h3 id="sect1269"><span class="b_heading">5.2 Aziridines showing activity against cysteine proteases</span></h3>
        <span>Schirmeister <span class="italic">et al.</span> reported a series of aziridine-2,3-dicarboxylate derivatives as potent irreversible inhibitors of cysteine proteases, which are involved in the life cycle of parasites that cause tropical disease such as malaria. The best activity was shown by compound <strong>344</strong> with a <span class="italic">K</span><small><sub>i</sub></small> value of 4.5 μM (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit99"><sup><span class="sup_ref">99</span></sup></a></span>
      
      
        
        <h3 id="sect1279"><span class="b_heading">5.3 Aziridines showing activity against tuberculosis</span></h3>
        <span>The <span class="italic">in vitro</span> antitubercular activity of aziridine derivatives against <span class="italic">Mycobacterium tuberculosis</span> was evaluated by Gandhimathi <span class="italic">et al.</span> in 2021. Promising activity was reported for derivative <strong>345</strong> with a minimum inhibitory concentration (MIC) value of 0.5 μg mL<small><sup>−1</sup></small> (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit100"><sup><span class="sup_ref">100</span></sup></a></span>
      
      
        
        <h3 id="sect1290"><span class="b_heading">5.4 Aziridines showing antimicrobial activity</span></h3>
        <span>The antimicrobial activity of functionalized 2-arylaziridines was identified by Luisi and co-workers. The most interesting compound is derivative <strong>346</strong> which showed a selective antibacterial activity against <span class="italic">Enterococcus faecalis</span> 29212 (MIC = 16 μg mL<small><sup>−1</sup></small>) and an interesting antifungal action against <span class="italic">Candida krusei</span> 6258 (MIC = 16 μg mL<small><sup>−1</sup></small>) (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit101a"><sup><span class="sup_ref">101a</span></sup></a></span>
      
      
        
        <h3 id="sect1302"><span class="b_heading">5.5 Aziridines showing activity against <span class="italic">Leishmania</span></span></h3>
        <span>Sharlow <span class="italic">et al.</span> described tretazicar (CB1954, 5-(aziridin-1-yl)-2,4-dinitrobenzamide, <strong>347</strong>) as a potent inhibitor of the <span class="italic">Leishmania</span> parasite. <span class="italic">In vivo</span> studies showed promising activity for curing cutaneous leishmaniasis, which is the most common form affecting humans (EC<small><sub>50</sub></small> = 0.05 μM in <span class="italic">L. major</span> cell-based amastigote) (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit102"><sup><span class="sup_ref">102</span></sup></a></span>
      
      
        
        <h3 id="sect1315"><span class="b_heading">5.6 Aziridines showing activity against oncological targets</span></h3>
        <span>Aziridine derivatives are well-known for possessing anti-cancer activity. Great efforts over the years have made it possible to discover potent active molecules.</span>
        <p class="otherpara">In 2021, Bulut and co-workers reported for the first time the synthesis of <span class="italic">N</span>-sugar substituted chiral aziridines <span class="italic">via</span> the Gabriel–Cromwell reaction. Among the newly prepared compounds were promising prodrug candidates for prostate (PC3) and cervical (HeLa) cancers. In particular, derivative <strong>348</strong> showed good activity with an IC<small><sub>50</sub></small> value of 23.55 μM for PC3 and 25.88 μM for HeLa (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit103"><sup><span class="sup_ref">103</span></sup></a></p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2023/OB/d3ob00424d/d3ob00424d-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d3ob00424d-f2.tif" src="/image/article/2023/OB/d3ob00424d/d3ob00424d-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Examples of aziridine derivatives with promising anticancer activity.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Kalvins <span class="italic">et al.</span> documented a class of acyl derivatives of aziridine-2-carboxylic acid as weak to moderately active PDIA1 (protein disulfide isomerase) inhibitors. Derivative <strong>349</strong> showed good inhibitory activity with an IC<small><sub>50</sub></small> value of 26.0 μM. The <span class="italic">in vitro</span> cytotoxicity value toward a panel of cells was also evaluated and promising results were achieved (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit104"><sup><span class="sup_ref">104</span></sup></a></p>
        <p class="otherpara">In 2022, a series of trifluromethyl-aziridine derivatives were reported as proteasome inhibitors, selective for the β5 subunit. The <span class="italic">in vitro</span> biological activity, both enzymatic inhibition and anti-proliferative profile against two leukemia cells lines, was evaluated and promising results were achieved. The best result was obtained for derivative <strong>350</strong> with an IC<small><sub>50</sub></small> value of 13.6 μM against the β5 subunit and 25.45 μM against drug-sensitive acute lymphocytic leukemia cells (CCRF-CEM) and 24.08 μM against a multidrug-resistant leukemia sub-cell line (CEM/ADR5000) (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit105"><sup><span class="sup_ref">105</span></sup></a></p>
        <p class="otherpara">Other anticancer aziridine bearing molecules were reported by Cheke <span class="italic">et al.</span> as inhibitors of the stem cell growth factor receptor often known as the c-KIT kinase domain. This is one of the 20 subfamilies of human receptor tyrosine kinases (RTKs) which is one of the main studied targets to fight cancer. The synthesized compounds were tested against the NCI-60 human cancer cell lines for a single-dose concentration. Derivative <strong>351</strong>, which was one of the most promising ones, was evaluated for a five-dose anticancer study showing an IC<small><sub>50</sub></small> value of 1.47 μM against different breast cancer cell lines (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit106"><sup><span class="sup_ref">106</span></sup></a></p>
        <p class="otherpara">Aziridines β-<span class="small_caps">D</span>-galactopyranoside derivatives were studied as anticancer agents by Calderón-Montaño and co-workers. The best result was obtained for compound <strong>352</strong>, which proved to induce DNA damage. The authors suggested that <strong>352</strong> has an anticancer therapeutic potential future since it showed selective cytotoxicity against different malignant cells in comparison with normal cells. In particular, the highest selectivity was observed for two acute promyelocytic leukemia cell lines, human acute promyelocytic leukemia cells (HL-60) and human acute promyelocytic leukemia cells (NB4) with an IC<small><sub>50</sub></small> value of 11.1 and 21.4 μM, respectively (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to references" href="#cit107"><sup><span class="sup_ref">107</span></sup></a></p>
      
    
    
      
      <h2 id="sect1354"><span class="a_heading">6. Conclusions</span></h2>
      <span>In conclusion, this overview of the recent advances in the chemistry of aziridine derivatives highlights the syntheses and chemical transformations of compounds bearing aziridine moieties. The variety of methodologies developed to prepare aziridines in the last three years speak for the importance of these compounds. Aziridines have been used as building blocks, for example as precursors for the preparation of more complex heterocycles or amino acids which are interesting from biological and pharmacological points of view due to various biological applications related to this class of compounds. Furthermore, several aziridine-bearing compounds themselves show promising biological activities. For these reasons, the interest in aziridines will endure and occupy scientists in the future too. Thus, we can expect more scientific breakthroughs reported in a rapid manner and in large numbers.</span>
    
    
      <h2 id="sect1358"><span class="a_heading">Conflicts of interest</span></h2>
      <span>The authors declare no conflict of interest.</span>
    
  
    <h2 id="sect1362"><span class="a_heading">Acknowledgements</span></h2>
      <span>The authors thank the University of Turin and the University of Vienna for financial support, Professor Vittorio Pace for his support, and Randy Sanichar for proofreading. The authors acknowledge support from Project CH4.0 under the MUR (Italian Ministry for the University) program “Dipartimenti di Eccellenza 2023–2027” (CUP: D13C22003520001).</span>
    
    <span id="sect1364"><h2 id="sect1361"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">J. B. Sweeney, <span class="italic">Chem. Soc. Rev.</span>, 2002, <span class="bold">31</span>, 247–258 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B006015L&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B006015L">RSC</a>.</span></li>
      <li><span id="cit2">
  (<i>&#97;</i>) <span id="cit2a">Y.-X. Cao, P. Silalai, C.-F. Liu, K.-Y. Yu, X. Bao, X.-H. Zhao, R. Saeeng and C.-A. Fan, <span class="italic">Chem. – Eur. J.</span>, 2021, <span class="bold">27</span>, 8473–8478 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.202100762" title="DOI Link to resource 10.1002/chem.202100762">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtFGmurzO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33844345%5Buid%5D" title="PubMed Link to resource 33844345">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit2b">S. Park, J. Koo, W. Kim and H. G. Lee, <span class="italic">Chem. Commun.</span>, 2022, <span class="bold">58</span>, 3767–3770 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D2CC00808D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D2CC00808D">RSC</a></span>; 
  (<i>&#99;</i>) <span id="cit2c">Y. I. Lichtenstein, I. S. Golovanov, S. L. Ioffe and A. A. Tabolin, <span class="italic">Tetrahedron</span>, 2022, <span class="bold">110</span>, 132693 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tet.2022.132693" title="DOI Link to resource 10.1016/j.tet.2022.132693">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XlvVantr8%253D" title="Link to resource in CAS">CAS</a></span>.</span></li>
      <li><span id="cit3">
  (<i>&#97;</i>) <span id="cit3a">Y. Zhou, A. K. Gupta, M. Mukherjee, L. Zheng and W. D. Wulff, <span class="italic">J. Org. Chem.</span>, 2017, <span class="bold">82</span>, 13121–13140 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.7b02184" title="DOI Link to resource 10.1021/acs.joc.7b02184">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhslent7nL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29084386%5Buid%5D" title="PubMed Link to resource 29084386">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit3b">M. Mukherjee, Y. Zhou, A. K. Gupta, Y. Guan and W. D. Wulff, <span class="italic">Eur. J. Org. Chem.</span>, 2014, 1386–1390 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.201301766" title="DOI Link to resource 10.1002/ejoc.201301766">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXht1yhsbs%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#99;</i>) <span id="cit3c">Y. Zhou, M. Mukherjee, A. K. Gupta and W. D. Wulff, <span class="italic">Org. Lett.</span>, 2017, <span class="bold">19</span>, 2230–2233 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.7b00697" title="DOI Link to resource 10.1021/acs.orglett.7b00697">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXmtV2ksbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28418256%5Buid%5D" title="PubMed Link to resource 28418256">PubMed</a></span>; 
  (<i>&#100;</i>) <span id="cit3d">X. Feng, Y. Song and W. Lin, <span class="italic">J. Am. Chem. Soc.</span>, 2021, <span class="bold">143</span>, 8184–8192 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.1c03561" title="DOI Link to resource 10.1021/jacs.1c03561">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtFamtbbK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34018731%5Buid%5D" title="PubMed Link to resource 34018731">PubMed</a></span>.</span></li>
      <li><span id="cit4">G. S. Singh, M. D'Hooghe and N. De Kimpe, <span class="italic">Chem. Rev.</span>, 2007, <span class="bold">107</span>, 2080–2135 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr0680033" title="DOI Link to resource 10.1021/cr0680033">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXltVSmurs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17488062%5Buid%5D" title="PubMed Link to resource 17488062">PubMed</a>.</span></li>
      <li><span id="cit5">T. Qadir, A. Amin, D. Sarkar and P. K. Sharma, <span class="italic">Curr. Org. Chem.</span>, 2021, <span class="bold">25</span>, 1868–1893 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/1385272825666210728100022" title="DOI Link to resource 10.2174/1385272825666210728100022">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXitl2jt7vP" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit6">M. Prieschl, D. Cantillo and C. O. Kappe, <span class="italic">J. Flow Chem.</span>, 2021, <span class="bold">11</span>, 117–125 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s41981-020-00125-2" title="DOI Link to resource 10.1007/s41981-020-00125-2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtVensL7L" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit7">
  (<i>&#97;</i>) <span id="cit7a">S. P. Chavan, S. A. Kawale and R. G. Gonnade, <span class="italic">Eur. J. Org. Chem.</span>, 2022, e202200384 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhvVChsbvF" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit7b">S. P. Chavan, A. L. Kadam, S. S. Shinde and R. G. Gonnade, <span class="italic">Chem. – Asian J.</span>, 2020, <span class="bold">15</span>, 415–424 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/asia.201901523" title="DOI Link to resource 10.1002/asia.201901523">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhsFSrs7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31794104%5Buid%5D" title="PubMed Link to resource 31794104">PubMed</a></span>.</span></li>
      <li><span id="cit8">L. A. McLean, M. W. Ashford, J. W. B. Fyfe, A. M. Z. Slawin, A. G. Leach and A. J. B. Watson, <span class="italic">Chem. – Eur. J.</span>, 2022, <span class="bold">28</span>, e202200060 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.202200060" title="DOI Link to resource 10.1002/chem.202200060">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XkvFSktrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35133031%5Buid%5D" title="PubMed Link to resource 35133031">PubMed</a>.</span></li>
      <li><span id="cit9">
  (<i>&#97;</i>) <span id="cit9a">I. Suzuki, Y. Takenaka, Y. Morishita and I. Shibata, <span class="italic">Chem. Lett.</span>, 2022, <span class="bold">51</span>, 9–12 <a target="_blank" class="DOILink" href="https://doi.org/10.1246/cl.210589" title="DOI Link to resource 10.1246/cl.210589">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhtVeqt7w%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit9b">J. L. Jat, A. K. Yadav, C. B. Pandey, D. Chandra and B. Tiwari, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 3751–3757 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.1c02785" title="DOI Link to resource 10.1021/acs.joc.1c02785">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XjslWnsb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35171590%5Buid%5D" title="PubMed Link to resource 35171590">PubMed</a></span>.</span></li>
      <li><span id="cit10">X. Fu, T. Zhang, J. Wu, Y. Sun and F. Wu, <span class="italic">Eur. J. Org. Chem.</span>, 2022, e202101205 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXis1KitrnO" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit11">G. Kirby, L. Grimaud, M. R. Vitale, G. Prestat and F. Berhal, <span class="italic">Green Chem.</span>, 2021, <span class="bold">23</span>, 9428–9432 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1GC03495B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1GC03495B">RSC</a>.</span></li>
      <li><span id="cit12">T. Deng, W. Mazumdar, Y. Yoshinaga, P. B. Patel, D. Malo, T. Malo, D. J. Wink and T. G. Driver, <span class="italic">J. Am. Chem. Soc.</span>, 2021, <span class="bold">143</span>, 19149–19159 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.1c09229" title="DOI Link to resource 10.1021/jacs.1c09229">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXisVWmu7nN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34748699%5Buid%5D" title="PubMed Link to resource 34748699">PubMed</a>.</span></li>
      <li><span id="cit13">J. Pérez-Ruíz, P. J. Pérez and M. M. Díaz-Requejo, <span class="italic">Organometallics</span>, 2022, <span class="bold">41</span>, 3349–3355 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.organomet.2c00310" title="DOI Link to resource 10.1021/acs.organomet.2c00310">CrossRef</a>.</span></li>
      <li><span id="cit14">M. R. Rodríguez, A. M. Rodríguez, S. López-Resano, M. A. Pericàs, M. M. Díaz-Requejo, F. Maseras and P. J. Pérez, <span class="italic">ACS Catal.</span>, 2023, <span class="bold">13</span>, 706–713 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acscatal.2c05069" title="DOI Link to resource 10.1021/acscatal.2c05069">CrossRef</a>.</span></li>
      <li><span id="cit15">Q. Zhao, Q.-Y. Yao, Y.-J. Zhang, T. Xu, J. Zhang and X. Chen, <span class="italic">Eur. J. Org. Chem.</span>, 2022, e202200790 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XisFaqtLzE" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit16">V. Boquet, A. Nasrallah, A. L. Dana, E. Brunard, P. H. Di Chenna, F. J. Duran, P. Retailleau, B. Darses, M. Sircoglou and P. Dauban, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 17156–17164 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c07337" title="DOI Link to resource 10.1021/jacs.2c07337">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitlGjsLzN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36094904%5Buid%5D" title="PubMed Link to resource 36094904">PubMed</a>.</span></li>
      <li><span id="cit17">D. K. Wolgemuth, S. D. Elmore, J. D. Cope, P. E. Sheridan, S. L. Stokes and J. P. Emerson, <span class="italic">Catal. Commun.</span>, 2021, <span class="bold">150</span>, 106275 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.catcom.2020.106275" title="DOI Link to resource 10.1016/j.catcom.2020.106275">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXjtVOjtQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit18">A. A. Pinarci, N. Daniecki, T. M. TenHoeve, B. Dellosso, R. Madiu, L. Mejia, S. E. Bektas and G. Moura-Letts, <span class="italic">Chem. Commun.</span>, 2022, <span class="bold">58</span>, 4909–4912 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D2CC00686C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D2CC00686C">RSC</a>.</span></li>
      <li><span id="cit19">D. Chandra, A. K. Yadav, V. Singh, B. Tiwari and J. L. Jat, <span class="italic">ChemistrySelect</span>, 2021, <span class="bold">6</span>, 10524–10526 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/slct.202102884" title="DOI Link to resource 10.1002/slct.202102884">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXit12lsL3O" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit20">X. Cheng, B.-G. Cai, H. Mao, J. Lu, L. Li, K. Wang and J. Xuan, <span class="italic">Org. Lett.</span>, 2021, <span class="bold">23</span>, 4109–4114 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c00979" title="DOI Link to resource 10.1021/acs.orglett.1c00979">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtFSmtb3M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33989004%5Buid%5D" title="PubMed Link to resource 33989004">PubMed</a>.</span></li>
      <li><span id="cit21">Y. Guo, C. Pei, S. Jana and R. M. Koenigs, <span class="italic">ACS Catal.</span>, 2021, <span class="bold">11</span>, 337–342 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acscatal.0c04564" title="DOI Link to resource 10.1021/acscatal.0c04564">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXis1aitb7E" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit22">X. Riart-Ferrer, P. Sang, J. Tao, H. Xu, L.-M. Jin, H. Lu, X. Cui, L. Wojtas and X. P. Zhang, <span class="italic">Chem</span>, 2021, <span class="bold">7</span>, 1120–1134 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXnvVals74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit23">
  (<i>&#97;</i>) <span id="cit23a">L. Degennaro, P. Trinchera and R. Luisi, <span class="italic">Chem. Rev.</span>, 2014, <span class="bold">114</span>, 7881–7929 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr400553c" title="DOI Link to resource 10.1021/cr400553c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXotVahtLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24823261%5Buid%5D" title="PubMed Link to resource 24823261">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit23b">M. Jia and S. Ma, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 9134–9166 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201508119" title="DOI Link to resource 10.1002/anie.201508119">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhtVSjsb%252FI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27310878%5Buid%5D" title="PubMed Link to resource 27310878">PubMed</a></span>.</span></li>
      <li><span id="cit24">J. L. Jat, D. Chandra, P. Kumar, V. Singh and B. Tiwari, <span class="italic">Synthesis</span>, 2022, 4513–4520 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/a-1879-7974" title="DOI Link to resource 10.1055/a-1879-7974">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitVehsrnJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit25">
  (<i>&#97;</i>) <span id="cit25a">J. Chen, W.-Q. Yan, C. M. Lam, C.-C. Zeng, L.-M. Hu and R. D. Little, <span class="italic">Org. Lett.</span>, 2015, <span class="bold">17</span>, 986–989 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.5b00083" title="DOI Link to resource 10.1021/acs.orglett.5b00083">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXit1SntrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25654310%5Buid%5D" title="PubMed Link to resource 25654310">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit25b">M. Ošeka, G. Laudadio, N. P. van Leest, M. Dyga, A. D. A. Bartolomeu, L. J. Gooßen, B. de Bruin, K. T. de Oliveira and T. Noël, <span class="italic">Chem</span>, 2021, <span class="bold">7</span>, 255–266 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.chempr.2020.12.002" title="DOI Link to resource 10.1016/j.chempr.2020.12.002">CrossRef</a></span>.</span></li>
      <li><span id="cit26">D. E. Holst, D. J. Wang, M. J. Kim, I. A. Guzei and Z. K. Wickens, <span class="italic">Nature</span>, 2021, <span class="bold">596</span>, 74–79 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41586-021-03717-7" title="DOI Link to resource 10.1038/s41586-021-03717-7">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhs1KmtrnN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34157720%5Buid%5D" title="PubMed Link to resource 34157720">PubMed</a>.</span></li>
      <li><span id="cit27">M.-S. Liu, H.-W. Du, J.-F. Cui and W. Shu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2022, <span class="bold">61</span>, e202209929 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitlClt7bP" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit28">W. Xue, Z. Zhu, S. Chen, B. You and C. Tang, <span class="italic">J. Am. Chem. Soc.</span>, 2023, <span class="bold">145</span>, 4142–4149 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c12344" title="DOI Link to resource 10.1021/jacs.2c12344">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXisl2htr4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36753512%5Buid%5D" title="PubMed Link to resource 36753512">PubMed</a>.</span></li>
      <li><span id="cit29">F. Sebest, L. Radtanajiravong, S. Kaukver, A. J. P. White and S. Díez-González, <span class="italic">Chem. Commun.</span>, 2022, <span class="bold">58</span>, 3681–3684 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1CC07213G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1CC07213G">RSC</a>.</span></li>
      <li><span id="cit30">
  (<i>&#97;</i>) <span id="cit30a">M. A. Marsini, J. T. Reeves, J.-N. Desrosiers, M. A. Herbage, J. Savoie, Z. Li, K. R. Fandrick, C. A. Sader, B. McKibben, D. A. Gao, J. Cui, N. C. Gonnella, H. Lee, X. Wei, F. Roschangar, B. Z. Lu and C. H. Senanayake, <span class="italic">Org. Lett.</span>, 2015, <span class="bold">17</span>, 5614–5617 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.5b02838" title="DOI Link to resource 10.1021/acs.orglett.5b02838">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvVejurzF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26558319%5Buid%5D" title="PubMed Link to resource 26558319">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit30b">T. Boultwood, D. P. Affron and J. A. Bull, <span class="italic">Tetrahedron</span>, 2015, <span class="bold">71</span>, 4949–4957 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tet.2015.05.098" title="DOI Link to resource 10.1016/j.tet.2015.05.098">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXps1ehsbo%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#99;</i>) <span id="cit30c">M. J. Kerner, C. A. Kuttruff, M. Chevliakov, F. G. Buono, D. A. Gao, M. Krawiec, C. A. Busacca, C. H. Senanayake, P. Wipf and J. T. Reeves, <span class="italic">Org. Lett.</span>, 2021, <span class="bold">23</span>, 4396–4399 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c01334" title="DOI Link to resource 10.1021/acs.orglett.1c01334">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtFSmtbzF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33988373%5Buid%5D" title="PubMed Link to resource 33988373">PubMed</a></span>.</span></li>
      <li><span id="cit31">A. Giovine, B. Musio, L. Degennaro, A. Falcicchio, A. Nagaki, J.-I. Yoshida and R. Luisi, <span class="italic">Chem. – Eur. J.</span>, 2013, <span class="bold">19</span>, 1872–1876 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201203533" title="DOI Link to resource 10.1002/chem.201203533">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXosFOrsg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23322634%5Buid%5D" title="PubMed Link to resource 23322634">PubMed</a>.</span></li>
      <li><span id="cit32">N. A. Meanwell, <span class="italic">J. Med. Chem.</span>, 2018, <span class="bold">61</span>, 5822–5880 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI Link to resource 10.1021/acs.jmedchem.7b01788">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29400967%5Buid%5D" title="PubMed Link to resource 29400967">PubMed</a>.</span></li>
      <li><span id="cit33">M. D. Delost and J. T. Njardarson, <span class="italic">Org. Lett.</span>, 2021, <span class="bold">23</span>, 6121–6125 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c02204" title="DOI Link to resource 10.1021/acs.orglett.1c02204">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhs1Kqs7zI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34292753%5Buid%5D" title="PubMed Link to resource 34292753">PubMed</a>.</span></li>
      <li><span id="cit34">M. D. Delost and J. T. Njardarson, <span class="italic">Org. Lett.</span>, 2020, <span class="bold">22</span>, 6917–6921 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.0c02448" title="DOI Link to resource 10.1021/acs.orglett.0c02448">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhs1CksbbE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32822201%5Buid%5D" title="PubMed Link to resource 32822201">PubMed</a>.</span></li>
      <li><span id="cit35">P. V. Kattamuri, J. Zhao, T. K. Das, J. H. Siitonen, N. Morgan, D. H. Ess and L. Kürti, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 10943–10949 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c03805" title="DOI Link to resource 10.1021/jacs.2c03805">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhsVKgt7%252FE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35674783%5Buid%5D" title="PubMed Link to resource 35674783">PubMed</a>.</span></li>
      <li><span id="cit36">L. Ielo, S. Touqeer, A. Roller, T. Langer, W. Holzer and V. Pace, <span class="italic">Angew. Chem., Int. Ed.</span>, 2019, <span class="bold">58</span>, 2479–2484 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201812525" title="DOI Link to resource 10.1002/anie.201812525">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSns70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30548145%5Buid%5D" title="PubMed Link to resource 30548145">PubMed</a>.</span></li>
      <li><span id="cit37">G. Parisi, M. Colella, S. Monticelli, G. Romanazzi, W. Holzer, T. Langer, L. Degennaro, V. Pace and R. Luisi, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 13648–13651 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b07891" title="DOI Link to resource 10.1021/jacs.7b07891">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2iurfF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28892363%5Buid%5D" title="PubMed Link to resource 28892363">PubMed</a>.</span></li>
      <li><span id="cit38">S. Monticelli, M. Colella, V. Pillari, A. Tota, T. Langer, W. Holzer, L. Degennaro, R. Luisi and V. Pace, <span class="italic">Org. Lett.</span>, 2019, <span class="bold">21</span>, 584–588 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.8b04001" title="DOI Link to resource 10.1021/acs.orglett.8b04001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXlvFWl" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30600682%5Buid%5D" title="PubMed Link to resource 30600682">PubMed</a>.</span></li>
      <li><span id="cit39">B. Wölfl, N. Winter, J. Li, A. Noble and V. K. Aggarwal, <span class="italic">Angew. Chem., Int. Ed.</span>, 2023, <span class="bold">62</span>, e202217064 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202217064" title="DOI Link to resource 10.1002/anie.202217064">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36507714%5Buid%5D" title="PubMed Link to resource 36507714">PubMed</a>.</span></li>
      <li><span id="cit40">M. Andresini, L. Degannaro and R. Luisi, <span class="italic">Beilstein J. Org. Chem.</span>, 2021, <span class="bold">17</span>, 203–209 <a target="_blank" class="DOILink" href="https://doi.org/10.3762/bjoc.17.20" title="DOI Link to resource 10.3762/bjoc.17.20">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXjt1Wltr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33564330%5Buid%5D" title="PubMed Link to resource 33564330">PubMed</a>.</span></li>
      <li><span id="cit41">G. S. Bisht, T. D. Dunchu and B. Gnanaprakasam, <span class="italic">Chem. – Asian J.</span>, 2021, <span class="bold">16</span>, 656–665 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/asia.202001418" title="DOI Link to resource 10.1002/asia.202001418">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXjvVekurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33464707%5Buid%5D" title="PubMed Link to resource 33464707">PubMed</a>.</span></li>
      <li><span id="cit42">H. Tao, R. Ushimaru, T. Awakawa, T. Mori, M. Uchiyama and I. Abe, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 21512–21520 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c08116" title="DOI Link to resource 10.1021/jacs.2c08116">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XivVylsLjE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36395461%5Buid%5D" title="PubMed Link to resource 36395461">PubMed</a>.</span></li>
      <li><span id="cit43">S. Kurosawa, F. Hasebe, H. Okamura, A. Yoshida, K. Matsuda, Y. Sone, T. Tomita, T. Shinada, H. Takikawa, T. Kuzuyama, S. Kosono and M. Nishiyama, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 16164–16170 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c07243" title="DOI Link to resource 10.1021/jacs.2c07243">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitF2hu7zO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35998388%5Buid%5D" title="PubMed Link to resource 35998388">PubMed</a>.</span></li>
      <li><span id="cit44">
  (<i>&#97;</i>) <span id="cit44a">A. Hensel, K. Nagura, L. B. Delvos and M. Oestreich, <span class="italic">Angew. Chem., Int. Ed.</span>, 2014, <span class="bold">53</span>, 4964–4967 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201402086" title="DOI Link to resource 10.1002/anie.201402086">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXlsFyhurs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24700790%5Buid%5D" title="PubMed Link to resource 24700790">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit44b">T. Mita, M. Sugawara, K. Saito and Y. Sato, <span class="italic">Org. Lett.</span>, 2014, <span class="bold">16</span>, 3028–3031 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol501143c" title="DOI Link to resource 10.1021/ol501143c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXotFOitbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24834796%5Buid%5D" title="PubMed Link to resource 24834796">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit44c">C. Zhao, C. Jiang, J. Wang, C. Wu, Q.-W. Zhang and W. He, <span class="italic">Asian J. Org. Chem.</span>, 2014, <span class="bold">3</span>, 851–855 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ajoc.201402077" title="DOI Link to resource 10.1002/ajoc.201402077">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlakt73N" title="Link to resource in CAS">CAS</a></span>.</span></li>
      <li><span id="cit45">Z.-Y. Zhao, M. Cui, E. Irran and M. Oestreich, <span class="italic">Angew. Chem., Int. Ed.</span>, 2023, <span class="bold">62</span>, e202215032 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXntFWhug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit46">
  (<i>&#97;</i>) <span id="cit46a">A. P. Molchanov, M. M. Efremova, M. A. Kryukova and M. A. Kuznetsov, <span class="italic">Beilstein J. Org. Chem.</span>, 2020, <span class="bold">16</span>, 2679–2686 <a target="_blank" class="DOILink" href="https://doi.org/10.3762/bjoc.16.218" title="DOI Link to resource 10.3762/bjoc.16.218">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33178358%5Buid%5D" title="PubMed Link to resource 33178358">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit46b">S. Hajra and A. Biswas, <span class="italic">Org. Lett.</span>, 2020, <span class="bold">22</span>, 4990–4994 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.0c01526" title="DOI Link to resource 10.1021/acs.orglett.0c01526">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtFGnsr7E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32543203%5Buid%5D" title="PubMed Link to resource 32543203">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit46c">A. Viceriat, I. Marchand, S. Carret and J.-F. Poisson, <span class="italic">Org. Lett.</span>, 2021, <span class="bold">23</span>, 2449–2454 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c00335" title="DOI Link to resource 10.1021/acs.orglett.1c00335">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXmtVOrs7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33705148%5Buid%5D" title="PubMed Link to resource 33705148">PubMed</a></span>; 
  (<i>&#100;</i>) <span id="cit46d">Y. Chen, J. Ling, A. B. Keto, Y. He, K.-H. Low, E. H. Krenske and P. Chiu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2022, <span class="bold">61</span>, e202116099 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XnvFWqu7o%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#101;</i>) <span id="cit46e">T. Zhang, S. Wang, D. Zuo, J. Zhao, W. Luo, C. Wang and P. Li, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 10408–10415 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.2c00710" title="DOI Link to resource 10.1021/acs.joc.2c00710">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhvFaiurnF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35892153%5Buid%5D" title="PubMed Link to resource 35892153">PubMed</a></span>.</span></li>
      <li><span id="cit47">
  (<i>&#97;</i>) <span id="cit47a">A. Biswas and S. Hajra, <span class="italic">Adv. Synth. Catal.</span>, 2022, <span class="bold">364</span>, 3035–3042 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202200514" title="DOI Link to resource 10.1002/adsc.202200514">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitFSktLbI" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit47b">S. Xing, Y. Wang, C. Jin, S. Shi, Y. Zhang, Z. Liao, K. Wang and B. Zhu, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 6426–6431 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.2c00287" title="DOI Link to resource 10.1021/acs.joc.2c00287">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhtVaitLbJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35439001%5Buid%5D" title="PubMed Link to resource 35439001">PubMed</a></span>.</span></li>
      <li><span id="cit48">Y. Hu, L. Yang and X. Liu, <span class="italic">Molecules</span>, 2023, <span class="bold">28</span>, 242 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules28010242" title="DOI Link to resource 10.3390/molecules28010242">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXpvFKnsg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36615437%5Buid%5D" title="PubMed Link to resource 36615437">PubMed</a>.</span></li>
      <li><span id="cit49">J. Qiao, S. Wang, X. Liu and X. Feng, <span class="italic">Chem. – Eur. J.</span>, 2023, <span class="bold">29</span>, e202203757 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.202203757" title="DOI Link to resource 10.1002/chem.202203757">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXjvFCgsLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36602265%5Buid%5D" title="PubMed Link to resource 36602265">PubMed</a>.</span></li>
      <li><span id="cit50">H. Zhu, P.-P. Zhou and Y. Wang, <span class="italic">Nat. Commun.</span>, 2022, <span class="bold">13</span>, 3563 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-022-31293-5" title="DOI Link to resource 10.1038/s41467-022-31293-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhsF2murzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35732663%5Buid%5D" title="PubMed Link to resource 35732663">PubMed</a>.</span></li>
      <li><span id="cit51">
  (<i>&#97;</i>) <span id="cit51a">R. Li, B. Li, H. Zhang, C.-W. Ju, Y. Qin, X.-S. Xue and D. Zhao, <span class="italic">Nat. Chem.</span>, 2021, <span class="bold">13</span>, 1006–1016 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41557-021-00746-7" title="DOI Link to resource 10.1038/s41557-021-00746-7">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhsF2msbjF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34282307%5Buid%5D" title="PubMed Link to resource 34282307">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit51b">Q. Wu and J. Xu, <span class="italic">Chem. Commun.</span>, 2022, <span class="bold">58</span>, 2714–2717 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1CC06535A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1CC06535A">RSC</a></span>.</span></li>
      <li><span id="cit52">Y.-F. Han, Z.-H. Gao, C.-L. Zhang and S. Ye, <span class="italic">Org. Lett.</span>, 2020, <span class="bold">22</span>, 8396–8400 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.0c03026" title="DOI Link to resource 10.1021/acs.orglett.0c03026">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXitVeqsrfM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33048556%5Buid%5D" title="PubMed Link to resource 33048556">PubMed</a>.</span></li>
      <li><span id="cit53">S. K. A. Saleh, A. Hazra, M. S. Singh and S. Hajra, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 8656–8671 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.2c00863" title="DOI Link to resource 10.1021/acs.joc.2c00863">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhsFKiur%252FE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35731944%5Buid%5D" title="PubMed Link to resource 35731944">PubMed</a>.</span></li>
      <li><span id="cit54">D. Zuo, T. Zhang, J. Zhao, W. Luo, C. Wang and P. Li, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 4630–4634 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c01739" title="DOI Link to resource 10.1021/acs.orglett.2c01739">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xhs1Sisb3N" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35731896%5Buid%5D" title="PubMed Link to resource 35731896">PubMed</a>.</span></li>
      <li><span id="cit55">Q. Wang, T. Fan and J. Song, <span class="italic">Org. Lett.</span>, 2023, <span class="bold">25</span>, 1246–1251 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c04124" title="DOI Link to resource 10.1021/acs.orglett.2c04124">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXjs1Cgu7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36815719%5Buid%5D" title="PubMed Link to resource 36815719">PubMed</a>.</span></li>
      <li><span id="cit56">C.-C. Wang, X.-L. Wang, Q.-L. Zhang, J. Liu, Z.-W. Ma, Z.-J. Liu and Y.-J. Chen, <span class="italic">Org. Chem. Front.</span>, 2022, <span class="bold">9</span>, 1574–1579 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1QO01926K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1QO01926K">RSC</a>.</span></li>
      <li><span id="cit57">J. Eshon, K. A. Nicastri, S. C. Schmid, W. T. Raskopf, I. A. Guzei, I. Fernández and J. M. Schomaker, <span class="italic">Nat. Commun.</span>, 2020, <span class="bold">11</span>, 1273 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-020-15134-x" title="DOI Link to resource 10.1038/s41467-020-15134-x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Shurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32152321%5Buid%5D" title="PubMed Link to resource 32152321">PubMed</a>.</span></li>
      <li><span id="cit58">X. Chen, Z. Huang and J. Xu, <span class="italic">Adv. Synth. Catal.</span>, 2021, <span class="bold">363</span>, 3098–3108 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202100320" title="DOI Link to resource 10.1002/adsc.202100320">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtVCrtLjI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit59">Y. Lei and J. Xu, <span class="italic">Beilstein J. Org. Chem.</span>, 2022, <span class="bold">18</span>, 70–76 <a target="_blank" class="DOILink" href="https://doi.org/10.3762/bjoc.18.6" title="DOI Link to resource 10.3762/bjoc.18.6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xhs1GgsL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35047083%5Buid%5D" title="PubMed Link to resource 35047083">PubMed</a>.</span></li>
      <li><span id="cit60">D. C. Miller, R. G. Lal, L. A. Marchetti and F. H. Arnold, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 4739–4745 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c00251" title="DOI Link to resource 10.1021/jacs.2c00251">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XmtVCnt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35258294%5Buid%5D" title="PubMed Link to resource 35258294">PubMed</a>.</span></li>
      <li><span id="cit61">P. Sonzini, N. Berthet, C. Damiano, V. Dufaud and E. Gallo, <span class="italic">J. Catal.</span>, 2022, <span class="bold">414</span>, 143–154 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jcat.2022.08.036" title="DOI Link to resource 10.1016/j.jcat.2022.08.036">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XisVans7bM" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit62">M. Cavalleri, C. Damiano, G. Manca and E. Gallo, <span class="italic">Chem. – Eur. J.</span>, 2023, <span class="bold">29</span>, e202202729 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.202202729" title="DOI Link to resource 10.1002/chem.202202729">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XivVKksLvI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36194105%5Buid%5D" title="PubMed Link to resource 36194105">PubMed</a>.</span></li>
      <li><span id="cit63">N. Panza, M. Alberti, S. Galiè, C. Damiano, F. Cargnoni, M. Italo Trioni and A. Caselli, <span class="italic">Eur. J. Org. Chem.</span>, 2022, e202200908 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XislensLjE" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit64">X.-R. Tian, X.-L. Jiang, S.-L. Hou, Z.-H. Jiao, J. Han and B. Zhao, <span class="italic">Angew. Chem., Int. Ed.</span>, 2022, <span class="bold">61</span>, e202200123 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xms1Oltr8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit65">P. Nayak, A. Chandrasekar Murali, V. Rao Velpuri, V. Chandrasekhar and K. Venkatasubbaiah, <span class="italic">Adv. Synth. Catal.</span>, 2023, <span class="bold">365</span>, 230–237 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202201253" title="DOI Link to resource 10.1002/adsc.202201253">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhtFGqsbo%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit66">H. J. Dequina, J. Eshon, S. C. Schmid, W. T. Raskopf, K. M. Sanders, I. Fernández and J. M. Schomaker, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 10902–10907 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.2c01186" title="DOI Link to resource 10.1021/acs.joc.2c01186">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitVyjsLjE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35947772%5Buid%5D" title="PubMed Link to resource 35947772">PubMed</a>.</span></li>
      <li><span id="cit67">G. V. Karunakar, K. Sunil, P. Bharath kumar, M. Chandrappa, R. Guduru, S. Kantevari and B. Sridhar, <span class="italic">Chem. – Asian J.</span>, 2023, <span class="bold">18</span>, e202201071 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/asia.202201071" title="DOI Link to resource 10.1002/asia.202201071">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXhtVGitLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36567599%5Buid%5D" title="PubMed Link to resource 36567599">PubMed</a>.</span></li>
      <li><span id="cit68">
  (<i>&#97;</i>) <span id="cit68a">S. Hajra, A. Hazra, S. K. A. Saleh and A. S. Mondal, <span class="italic">Org. Lett.</span>, 2019, <span class="bold">21</span>, 10154–10158 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.9b04229" title="DOI Link to resource 10.1021/acs.orglett.9b04229">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitleisbnP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31821000%5Buid%5D" title="PubMed Link to resource 31821000">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit68b">C.-Y. Liu, V. Angamuthu, W.-C. Chen and D.-R. Hou, <span class="italic">Org. Lett.</span>, 2020, <span class="bold">22</span>, 2246–2250 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.0c00443" title="DOI Link to resource 10.1021/acs.orglett.0c00443">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXktVSntL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32115955%5Buid%5D" title="PubMed Link to resource 32115955">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit68c">D. A. Vasilenko, S. E. Dronov, Y. K. Grishin and E. B. Averina, <span class="italic">Asian J. Org. Chem.</span>, 2022, <span class="bold">11</span>, e202200355 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ajoc.202200355" title="DOI Link to resource 10.1002/ajoc.202200355">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitFSltL3M" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#100;</i>) <span id="cit68d">H. M. Holst, J. T. Floreancig, C. B. Ritts and N. J. Race, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 501–505 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c03857" title="DOI Link to resource 10.1021/acs.orglett.1c03857">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXivVChu7vE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34967220%5Buid%5D" title="PubMed Link to resource 34967220">PubMed</a></span>.</span></li>
      <li><span id="cit69">
  (<i>&#97;</i>) <span id="cit69a">S. Nagamalla, D. Paul, J. T. Mague and S. Sathyamoorthi, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 6202–6207 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c02496" title="DOI Link to resource 10.1021/acs.orglett.2c02496">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitFWktLrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35951966%5Buid%5D" title="PubMed Link to resource 35951966">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit69b">I. A. Wani, S. Sk, A. Mal, A. Sengupta and M. K. Ghorai, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 7867–7872 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c02354" title="DOI Link to resource 10.1021/acs.orglett.2c02354">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XitlCksb%252FL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36094406%5Buid%5D" title="PubMed Link to resource 36094406">PubMed</a></span>.</span></li>
      <li><span id="cit70">X. Chen, Y. Lei, D. Fu and J. Xu, <span class="italic">Org. Biomol. Chem.</span>, 2021, <span class="bold">19</span>, 7678–7689 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1OB01359A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1OB01359A">RSC</a>.</span></li>
      <li><span id="cit71">S. Xing, C. Wang, T. Gao, Y. Wang, H. Wang, H. Wang, K. Wang and B. Zhu, <span class="italic">New J. Chem.</span>, 2022, <span class="bold">46</span>, 2553–2558 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1NJ05031A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1NJ05031A">RSC</a>.</span></li>
      <li><span id="cit72">A. Tracz, M. Malinowska, S. Leśniak and A. Zawisza, <span class="italic">Molecules</span>, 2022, <span class="bold">27</span>, 1764 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules27061764" title="DOI Link to resource 10.3390/molecules27061764">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XoslSisLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35335129%5Buid%5D" title="PubMed Link to resource 35335129">PubMed</a>.</span></li>
      <li><span id="cit73">J. Xin, T. Chen and P. Tang, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 2035–2039 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c00558" title="DOI Link to resource 10.1021/acs.orglett.2c00558">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xmt1Gnt74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35261244%5Buid%5D" title="PubMed Link to resource 35261244">PubMed</a>.</span></li>
      <li><span id="cit74">S. Dongbang and A. G. Doyle, <span class="italic">J. Am. Chem. Soc.</span>, 2022, <span class="bold">144</span>, 20067–20077 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.2c09294" title="DOI Link to resource 10.1021/jacs.2c09294">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xis1ekt7%252FK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36256882%5Buid%5D" title="PubMed Link to resource 36256882">PubMed</a>.</span></li>
      <li><span id="cit75">K. L. Jensen, E. A. Standley and T. F. Jamison, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 11145–11152 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja505823s" title="DOI Link to resource 10.1021/ja505823s">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2ltr3L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25055180%5Buid%5D" title="PubMed Link to resource 25055180">PubMed</a>.</span></li>
      <li><span id="cit76">S. Pache and M. Lautens, <span class="italic">Org. Lett.</span>, 2003, <span class="bold">5</span>, 4827–4830 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol035806t" title="DOI Link to resource 10.1021/ol035806t">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXovVOgsrg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14653684%5Buid%5D" title="PubMed Link to resource 14653684">PubMed</a>.</span></li>
      <li><span id="cit77">M. Bai, S. Jia, J. Zhang, H.-G. Cheng, H. Cong, S. Liu, Z. Huang, Y. Huang, X. Chen and Q. Zhou, <span class="italic">Angew. Chem., Int. Ed.</span>, 2022, <span class="bold">61</span>, e202205245 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xhs1ClsbfL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit78">J. Lee, X. Ju, M. Lee, Q. Jiang, H. Jang, W. S. Kim, L. Wu, S. Williams, X.-J. Wang, X. Zeng, J. Payne and Z. S. Han, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 2655–2659 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c00703" title="DOI Link to resource 10.1021/acs.orglett.2c00703">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XovVSiu7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35377668%5Buid%5D" title="PubMed Link to resource 35377668">PubMed</a>.</span></li>
      <li><span id="cit79">S. A. Saleh, A. Hazra and S. Hajra, <span class="italic">Adv. Synth. Catal.</span>, 2022, <span class="bold">364</span>, 391–404 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202100858" title="DOI Link to resource 10.1002/adsc.202100858">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXitlOmsL%252FN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit80">V. M. Dembitsky, <span class="italic">Eur. J. Med. Chem.</span>, 2008, <span class="bold">43</span>, 223–251 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2007.04.019" title="DOI Link to resource 10.1016/j.ejmech.2007.04.019">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXitlWqtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17618015%5Buid%5D" title="PubMed Link to resource 17618015">PubMed</a>.</span></li>
      <li><span id="cit81">H.-C. Chen, C.-Y. Liu, V. Angamuthu, W.-C. Chen, C.-S. Wen and D.-R. Hou, <span class="italic">Org. Lett.</span>, 2023, <span class="bold">25</span>, 190–194 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c04042" title="DOI Link to resource 10.1021/acs.orglett.2c04042">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XjtF2msr%252FO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36576235%5Buid%5D" title="PubMed Link to resource 36576235">PubMed</a>.</span></li>
      <li><span id="cit82">A. Ahmad, H. S. Dutta, M. Kumar, S. Raziullah, M. K. Gangwar and D. Koley, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 2783–2787 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c00120" title="DOI Link to resource 10.1021/acs.orglett.2c00120">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XptFerurw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35394290%5Buid%5D" title="PubMed Link to resource 35394290">PubMed</a>.</span></li>
      <li><span id="cit83">K.-X. Huang, Z.-Y. Chen, X.-G. Liu, H.-Y. Ye and W.-C. Gao, <span class="italic">Synthesis</span>, 2022, 4495–4502 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/a-1878-8084" title="DOI Link to resource 10.1055/a-1878-8084">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhvFGqt7%252FE" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit84">Y. Li, W.-Y. Li, X. Tang, X. Liu and X. Feng, <span class="italic">Org. Chem. Front.</span>, 2022, <span class="bold">9</span>, 1531–1535 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D1QO01900G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D1QO01900G">RSC</a>.</span></li>
      <li><span id="cit85">J. Davies, D. Janssen-Müller, D. P. Zimin, C. S. Day, T. Yanagi, J. Elfert and R. Martin, <span class="italic">J. Am. Chem. Soc.</span>, 2021, <span class="bold">143</span>, 4949–4954 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.1c01916" title="DOI Link to resource 10.1021/jacs.1c01916">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXmsVWjtrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33724815%5Buid%5D" title="PubMed Link to resource 33724815">PubMed</a>.</span></li>
      <li><span id="cit86">P. Fan, Y. Jin, J. Liu, R. Wang and C. Wang, <span class="italic">Org. Lett.</span>, 2021, <span class="bold">23</span>, 7364–7369 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c02514" title="DOI Link to resource 10.1021/acs.orglett.1c02514">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXitVOnsbjL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34543571%5Buid%5D" title="PubMed Link to resource 34543571">PubMed</a>.</span></li>
      <li><span id="cit87">H. D. Pickford, J. Nugent, B. Owen, J. J. Mousseau, R. C. Smith and E. A. Anderson, <span class="italic">J. Am. Chem. Soc.</span>, 2021, <span class="bold">143</span>, 9729–9736 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.1c04180" title="DOI Link to resource 10.1021/jacs.1c04180">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhsVShtLbJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34161076%5Buid%5D" title="PubMed Link to resource 34161076">PubMed</a>.</span></li>
      <li><span id="cit88">T. Song, L. Zhu, H. Li, C.-H. Tung, Y. Lan and Z. Xu, <span class="italic">Org. Lett.</span>, 2020, <span class="bold">22</span>, 2419–2424 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.0c00622" title="DOI Link to resource 10.1021/acs.orglett.0c00622">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXksVSgt7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32129634%5Buid%5D" title="PubMed Link to resource 32129634">PubMed</a>.</span></li>
      <li><span id="cit89">S. Xing, T. Gao, C. Jin, H. Dong, X. Shao, K. Wang and B. Zhu, <span class="italic">Adv. Synth. Catal.</span>, 2023, <span class="bold">365</span>, 104–109 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202201062" title="DOI Link to resource 10.1002/adsc.202201062">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXpsl2ksw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit90">
  (<i>&#97;</i>) <span id="cit90a">G. Coin, O. de Ferrier de Montal, P. Dubourdeaux and J.-M. Latour, <span class="italic">Eur. J. Org. Chem.</span>, 2021, 443–448 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejoc.202001379" title="DOI Link to resource 10.1002/ejoc.202001379">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXisFGls7vN" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit90b">A. S. Pankova, <span class="italic">J. Org. Chem.</span>, 2022, <span class="bold">87</span>, 11121–11130 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.2c01365" title="DOI Link to resource 10.1021/acs.joc.2c01365">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhvFGqtbbO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35905291%5Buid%5D" title="PubMed Link to resource 35905291">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit90c">L. Song, X. Tian, K. Farshadfar, F. Shiri, F. Rominger, A. Ariafard and A. S. K. Hashmi, <span class="italic">Nat. Commun.</span>, 2023, <span class="bold">14</span>, 831 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-023-36190-z" title="DOI Link to resource 10.1038/s41467-023-36190-z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXjtlKiu7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36788212%5Buid%5D" title="PubMed Link to resource 36788212">PubMed</a></span>.</span></li>
      <li><span id="cit91">F. Vuillermet, J. Bourret and G. Pelletier, <span class="italic">J. Org. Chem.</span>, 2021, <span class="bold">86</span>, 388–402 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.0c02148" title="DOI Link to resource 10.1021/acs.joc.0c02148">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXisFSntrbI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33269922%5Buid%5D" title="PubMed Link to resource 33269922">PubMed</a>.</span></li>
      <li><span id="cit92">H. Tan, S. Samanta, A. Maity, P. Roychowdhury and D. C. Powers, <span class="italic">Nat. Commun.</span>, 2022, <span class="bold">13</span>, 3341 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-022-31032-w" title="DOI Link to resource 10.1038/s41467-022-31032-w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhsFGrurbP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35689000%5Buid%5D" title="PubMed Link to resource 35689000">PubMed</a>.</span></li>
      <li><span id="cit93">Y. Zhu, M. J. S. Smith, W. Tu and J. Bower, <span class="italic">Angew. Chem., Int. Ed.</span>, 2023, <span class="bold">62</span>, e202301262 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202301262" title="DOI Link to resource 10.1002/anie.202301262">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3sXlsVSru7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36812298%5Buid%5D" title="PubMed Link to resource 36812298">PubMed</a>.</span></li>
      <li><span id="cit94">A. Cocco, M. G. Rubanu, M. L. Sechi, A. Frongia, P. Mastrorilli, L. Degennaro, M. Colella, R. Luisi and F. Secci, <span class="italic">Org. Biomol. Chem.</span>, 2021, <span class="bold">19</span>, 1945–1949 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0OB00771D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0OB00771D">RSC</a>.</span></li>
      <li><span id="cit95">A. Buchcic-Szychowska, J. Adamczyk, L. Marciniak, A. M. Pieczonka, A. Zawisza, S. Leśniak and M. Rachwalski, <span class="italic">Catalysts</span>, 2021, <span class="bold">11</span>, 968 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/catal11080968" title="DOI Link to resource 10.3390/catal11080968">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXitl2msbzK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit96">A. Buchcic-Szychowska, A. Zawisza, S. Leśniak and M. Rachwalski, <span class="italic">Catalysts</span>, 2022, <span class="bold">12</span>, 394 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/catal12040394" title="DOI Link to resource 10.3390/catal12040394">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhtFemt7rL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit97">
  (<i>&#97;</i>) <span id="cit97a">K. C. Nicolaou, Y. G. Shelke, B. D. Dherange, A. Kempema, B. Lin, C. Gu, J. Sandoval, M. Hammond, M. Aujay and J. Gavrilyuk, <span class="italic">J. Org. Chem.</span>, 2020, <span class="bold">85</span>, 2865–2917 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.0c00123" title="DOI Link to resource 10.1021/acs.joc.0c00123">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjtFansbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32065746%5Buid%5D" title="PubMed Link to resource 32065746">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit97b">S. Lin, Y. Liang, J. Cheng, F. Pan and Y. Wang, <span class="italic">Eur. J. Med. Chem.</span>, 2021, <span class="bold">214</span>, 113256 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2021.113256" title="DOI Link to resource 10.1016/j.ejmech.2021.113256">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXjvVClsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33581556%5Buid%5D" title="PubMed Link to resource 33581556">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit97c">V. Carramiñana, A. M. Ochoa de Retana, F. Palacios and J. M. de los Santos, <span class="italic">Molecules</span>, 2021, <span class="bold">26</span>, 4265 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules26144265" title="DOI Link to resource 10.3390/molecules26144265">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34299540%5Buid%5D" title="PubMed Link to resource 34299540">PubMed</a></span>.</span></li>
      <li><span id="cit98">R. J. Rowland, Y. Chen, I. Breen, L. Wu, W. A. Offen, T. J. Beenakker, Q. Su, A. M. C. H. van den Nieuwendijk, J. M. F. G. Aerts, M. Artola, H. S. Overkleeft and G. J. Davies, <span class="italic">Chem. – Eur. J.</span>, 2021, <span class="bold">27</span>, 16377–16388 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.202102359" title="DOI Link to resource 10.1002/chem.202102359">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXitlOlt7nO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34570911%5Buid%5D" title="PubMed Link to resource 34570911">PubMed</a>.</span></li>
      <li><span id="cit99">V. Buback, M. Mladenovic, B. Engels and T. Schirmeister, <span class="italic">J. Phys. Chem. B</span>, 2009, <span class="bold">113</span>, 5282–5289 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp810549n" title="DOI Link to resource 10.1021/jp810549n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXjsFemt74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19301885%5Buid%5D" title="PubMed Link to resource 19301885">PubMed</a>.</span></li>
      <li><span id="cit100">P. Sarojini, M. Jeyachandran, D. Sriram, P. Ranganathan and S. Gandhimathi, <span class="italic">J. Mol. Struct.</span>, 2021, <span class="bold">1233</span>, 130038 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.molstruc.2021.130038" title="DOI Link to resource 10.1016/j.molstruc.2021.130038">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXkvFelsLk%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit101">
  (<i>&#97;</i>) <span id="cit101a">A. Giovine, M. Muraglia, M. A. Florio, A. Rosato, F. Corbo, C. Franchini, B. Musio, L. Degennaro and R. Luisi, <span class="italic">Molecules</span>, 2014, <span class="bold">19</span>, 11505–11519 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules190811505" title="DOI Link to resource 10.3390/molecules190811505">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25093988%5Buid%5D" title="PubMed Link to resource 25093988">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit101b">H. K. Santra, S. Maity and D. Banerjee, <span class="italic">Molecules</span>, 2022, <span class="bold">27</span>, 1459 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules27051459" title="DOI Link to resource 10.3390/molecules27051459">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xntlehurs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35268559%5Buid%5D" title="PubMed Link to resource 35268559">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit101c">M. Pitscheider, N. Mäusbacher and S. A. Sieber, <span class="italic">Chem. Sci.</span>, 2012, <span class="bold">3</span>, 2035–2041 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2SC20290E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2SC20290E">RSC</a></span>; 
  (<i>&#100;</i>) <span id="cit101d">S. Ghannay, A. Kadri and K. Aouadi, <span class="italic">Monatsh. Chem.</span>, 2020, <span class="bold">151</span>, 267–280 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00706-020-02550-4" title="DOI Link to resource 10.1007/s00706-020-02550-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXivFKmu74%253D" title="Link to resource in CAS">CAS</a></span>.</span></li>
      <li><span id="cit102">D. Caridha, R. J. Sciotti, J. Sousa, B. Vesely, T. Teshome, G. Bonkoungou, C. Vuong, S. Leed, M. Khraiwesh, E. Penn, M. Kreishman-Deitrick, P. Lee, B. Pybus, J. S. Lazo and E. R. Sharlow, <span class="italic">ACS Infect. Dis.</span>, 2021, <span class="bold">7</span>, 506–517 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsinfecdis.0c00886" title="DOI Link to resource 10.1021/acsinfecdis.0c00886">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXisF2rtL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33529014%5Buid%5D" title="PubMed Link to resource 33529014">PubMed</a>.</span></li>
      <li><span id="cit103">M. Sert, Ö. Işılar, A. S. Yaglioglu and A. Bulut, <span class="italic">Carbohydr. Res.</span>, 2021, <span class="bold">509</span>, 108430 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.carres.2021.108430" title="DOI Link to resource 10.1016/j.carres.2021.108430">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhvFCrtLrI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=34488002%5Buid%5D" title="PubMed Link to resource 34488002">PubMed</a>.</span></li>
      <li><span id="cit104">I. Leite, V. Andrianov, D. Zelencova-Gopejenko, E. Loza, I. Kazhoka-Lapsa, I. Domracheva, M. Stoyak, S. Chlopicki and I. Kalvins, <span class="italic">Chem. Heterocycl. Compd.</span>, 2021, <span class="bold">57</span>, 1086–1106 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10593-021-03034-x" title="DOI Link to resource 10.1007/s10593-021-03034-x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XltlSgsQ%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit105">L. Ielo, V. Patamia, A. Citarella, T. Efferth, N. Shahhamzehei, T. Schirmeister, C. Stagno, T. Langer, A. Rescifina, N. Micale and V. Pace, <span class="italic">Int. J. Mol. Sci.</span>, 2022, <span class="bold">23</span>, 12363 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/ijms232012363" title="DOI Link to resource 10.3390/ijms232012363">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xisl2msLrK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=36293216%5Buid%5D" title="PubMed Link to resource 36293216">PubMed</a>.</span></li>
      <li><span id="cit106">P. J. Chaudhari, S. B. Bari, S. J. Surana, A. A. Shirkhedkar, C. G. Bonde, S. C. Khadse, V. G. Ugale, A. A. Nagar and R. S. Cheke, <span class="italic">ACS Omega</span>, 2022, <span class="bold">7</span>, 17270–17294 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsomega.2c01198" title="DOI Link to resource 10.1021/acsomega.2c01198">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38Xht1yhu7jK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35647471%5Buid%5D" title="PubMed Link to resource 35647471">PubMed</a>.</span></li>
      <li><span id="cit107">E. Burgos-Morón, N. Pastor, M. L. Orta, J. J. Jiménez-Alonso, C. Palo-Nieto, M. Vega-Holm, J. M. Vega-Pérez, F. Iglesias-Guerra, S. Mateos, M. López-Lázaro and J. M. Calderón-Montaño, <span class="italic">Biomedicines</span>, 2022, <span class="bold">10</span>, 41 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/biomedicines10010041" title="DOI Link to resource 10.3390/biomedicines10010041">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35052721%5Buid%5D" title="PubMed Link to resource 35052721">PubMed</a>.</span></li>
      <li><span id="cit108">C. C. Wang, Y. T. Yang, Q. L. Wang, X. H. Liu and Y. J. Chen, <span class="italic">Org. Chem. Front.</span>, 2022, <span class="bold">9</span>, 4271–4276 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D2QO00612J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D2QO00612J">RSC</a>.</span></li>
      <li><span id="cit109">F. Zhang, X. Sang, Y. Zhou, W. Cao and X. Feng, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 1513–1517 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.2c00190" title="DOI Link to resource 10.1021/acs.orglett.2c00190">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XjtlSktLw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35147442%5Buid%5D" title="PubMed Link to resource 35147442">PubMed</a>.</span></li>
      <li><span id="cit110">J. Xin, X. Deng and P. Tang, <span class="italic">Org. Lett.</span>, 2022, <span class="bold">24</span>, 881–885 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.1c04226" title="DOI Link to resource 10.1021/acs.orglett.1c04226">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB38XhtVSktb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=35023747%5Buid%5D" title="PubMed Link to resource 35023747">PubMed</a>.</span></li>
    </ol>
    
  <table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2023</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>